Please sign in to follow a disease.
Lung disorder
MONDO:0005275A disease involving the lung.
Also known as: disease of lung, disease or disorder of lung, disorder of lung, lung disease, lung disease or disorder, lung disorder, lung disorders, pulmonary disease
7078 clinical trials for this condition and its sub-types, 251 tagged with Lung disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Lung disorder
-
Lung neoplasm 1,367 trials · 4,039 incl. sub-types
10 sub-types
- Lung cancer 1,207 trials · 3,941 incl. sub-types Sub-types →
- Lung neuroendocrine neoplasm 21 trials · 540 incl. sub-types Sub-types →
- Lung benign neoplasm 1 trial · 2 incl. sub-types Sub-types →
- Lung PEComa 0 trials · 1 incl. sub-types Sub-types →
- Pulmonary sulcus neoplasm 0 trials · 1 incl. sub-types Sub-types →
- Langerhans cell histiocytosis specific to adulthood 0 trials Sub-types →
- Fibroma of lung 0 trials
- Hamartoma of lung 0 trials Sub-types →
- Lung germ cell tumor 0 trials
- Lung hilum neoplasm 0 trials Sub-types →
-
Obstructive lung disease 36 trials · 1,071 incl. sub-types
1 sub-type
- Chronic obstructive pulmonary disease 935 trials · 1,051 incl. sub-types Sub-types →
-
Respiratory failure 279 trials · 789 incl. sub-types
2 sub-types
- Acute respiratory failure 153 trials · 588 incl. sub-types Sub-types →
- Respiratory paralysis 20 trials
-
Interstitial lung disease 256 trials · 728 incl. sub-types
14 sub-types
- Idiopathic pulmonary fibrosis 202 trials
- Interstitial lung disease specific to childhood 5 trials · 163 incl. sub-types Sub-types →
- Pulmonary fibrosis 140 trials · 143 incl. sub-types Sub-types →
- Bronchiolitis obliterans syndrome 42 trials · 44 incl. sub-types Sub-types →
- Hypersensitivity pneumonitis 25 trials · 30 incl. sub-types Sub-types →
- Secondary pulmonary hemosiderosis 0 trials · 30 incl. sub-types Sub-types →
- Interstitial lung disease specific to adulthood 0 trials · 20 incl. sub-types Sub-types →
- Radiation pneumonitis 20 trials
- Pneumoconiosis 5 trials · 13 incl. sub-types Sub-types →
- Inherited interstitial lung disease 5 trials · 11 incl. sub-types Sub-types →
- Drug or radiation exposure-related interstitial lung disease 2 trials
- Bronchiolocentric pattern of interstitial pneumonia 0 trials
- Isolated pulmonary capillaritis 0 trials
- Pulmonary fibrosis-hepatic hyperplasia-bone marrow hypoplasia syndrome 0 trials
-
Pneumonitis 15 trials · 645 incl. sub-types
6 sub-types
- Pneumonia 326 trials · 610 incl. sub-types Sub-types →
- Hypersensitivity pneumonitis 25 trials · 30 incl. sub-types Sub-types →
- Radiation pneumonitis 20 trials
- Aspiration pneumonitis 2 trials Sub-types →
- Ichthyosis prematurity syndrome 1 trial
- Toxic pneumonitis 0 trials
-
Bronchiolitis 51 trials · 104 incl. sub-types
6 sub-types
- Bronchiolitis obliterans syndrome 42 trials · 44 incl. sub-types Sub-types →
- Acute bronchiolitis 19 trials
- Respiratory syncytial virus bronchiolitis 6 trials
- Postinfectious bronchiolitis obliterans 2 trials
- Mac-Leod-Swyer-James-Syndrome 0 trials
- Toxic bronchiolitis 0 trials Sub-types →
-
Acute lung injury 90 trials
-
Fungal lung infectious disease 6 trials · 57 incl. sub-types
5 sub-types
- Pulmonary aspergilloma 11 trials · 38 incl. sub-types Sub-types →
- Pneumocystosis 19 trials
- Adiaspiromycosis 0 trials
- Cork-handlers' disease 0 trials
- Maple bark strippers' lung 0 trials
-
Aspiration pneumonia 33 trials
-
Acute chest syndrome 30 trials
-
Middle lobe syndrome 29 trials
-
Pulmonary systemic sclerosis 27 trials
-
Pulmonary coin lesion 24 trials
-
Pulmonary alveolar proteinosis 9 trials · 13 incl. sub-types
3 sub-types
- Autoimmune pulmonary alveolar proteinosis 6 trials
- Hereditary pulmonary alveolar proteinosis 3 trials · 6 incl. sub-types Sub-types →
- Secondary pulmonary alveolar proteinosis 0 trials
-
Pulmonary artery disease 12 trials
-
Restrictive pulmonary disease 8 trials
-
Occupational lung disease 4 trials · 8 incl. sub-types
8 sub-types
- Occupational asthma 3 trials
- Bird fancier's lung 1 trial
- Bagassosis 0 trials
- Cork-handlers' disease 0 trials
- Farmer's lung disease 0 trials
- Malt worker's lung 0 trials
- Maple bark strippers' lung 0 trials
- Mushroom workers' lung 0 trials
-
Neonatal aspiration syndrome 1 trial · 6 incl. sub-types
2 sub-types
- Meconium aspiration syndrome 5 trials
- Massive neonatal aspiration syndrome 0 trials
-
Lung abscess 3 trials
-
Pneumonic plague 3 trials
-
Hantavirus pulmonary syndrome 2 trials
-
Pulmonary immaturity 2 trials
-
Wilson-Mikity syndrome 0 trials
-
Dystrophic pulmonary ossification 0 trials
-
Pulmonary alveolar microlithiasis 0 trials
-
Pulmonary embolism and infarction 0 trials
-
Pulmonary plasma cell granuloma 0 trials
-
Pulmonary venoocclusive disease 0 trials
2 sub-types
- Pulmonary venoocclusive disease 1 0 trials
- Pulmonary venoocclusive disease 2 0 trials
-
Shrinking lung syndrome 0 trials
-
Silo filler disease 0 trials
-
Vanishing lung syndrome 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 1012 trials in this tab.
-
Can your own immune cells fight advanced cancer?
Cure Not yet recruitingThis trial is testing an experimental therapy called IOV-5001, which uses a patient's own immune cells (tumor-infiltrating lymphocytes) to attack cancer. The study involves adults with advanced solid tumors, including non-small cell lung cancer, triple-negative breast cancer, col…
Phase 1/2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Cure
Last updated Sep 17, 2026 00:00 UTC
-
Can a Three-Dose immunotherapy cure early lung cancer without surgery?
Cure Not yet recruitingThis phase 2 trial tests whether three cycles of the immunotherapy drug cemiplimab can cure patients with stage I non-small cell lung cancer who cannot undergo surgery or radiation. Researchers will select patients likely to respond to immunotherapy and treat them with cemiplimab…
Phase 2 • Sponsor: The Netherlands Cancer Institute • Aim: Cure
Last updated Sep 10, 2026 00:00 UTC
-
Can a Triple-Drug combo before surgery eliminate EGFR-Mutant lung cancer?
Cure Not yet recruitingThis phase II trial tests whether giving a combination of firmonertinib, anlotinib, and chemotherapy before surgery can shrink or eliminate tumors in people with resectable EGFR-mutant non-small cell lung cancer. The study enrolls adults with stage IIA-IIIB disease who have speci…
Phase 2 • Sponsor: Hubei Cancer Hospital • Aim: Cure
Last updated Sep 10, 2026 00:00 UTC
-
Can a precise Lung-Sparing surgery beat standard lobectomy for early lung cancer?
Cure Not yet recruitingThis trial is testing a surgical technique called septum-guided segmentectomy for people with early-stage (2-3 cm) non-small cell lung cancer. The surgery aims to remove only the diseased part of the lung, guided by natural anatomical landmarks, while preserving healthy tissue. T…
Sponsor: Shanghai Chest Hospital • Aim: Cure
Last updated Aug 23, 2026 00:00 UTC
-
Can updated COVID-19 shots better protect High-Risk groups?
Vaccine Not yet recruitingThis Phase 3 trial tests updated versions of the BNT162b2 COVID-19 vaccine in adults and children aged 5 and older. Participants include those aged 5 to 64 with medical conditions that raise their risk of severe COVID-19, as well as everyone aged 65 and older. The study compares …
Phase 3 • Sponsor: BioNTech SE • Aim: Vaccine
Last updated Sep 03, 2026 00:00 UTC
-
Can a pneumonia vaccine protect the most vulnerable children?
Vaccine Not yet recruitingThis study tests whether a pneumococcal vaccine (Pneumosil) can produce a strong immune response in children aged 6-59 months who are hospitalised with severe acute malnutrition. Half the children will receive the pneumococcal vaccine, and the other half will receive a typhoid va…
Phase 4 • Sponsor: Nick Fancourt • Aim: Vaccine
Last updated Jun 27, 2026 08:05 UTC
-
Two-Drug combo targets stubborn KRAS lung cancer
Disease control Not yet recruitingResearchers are testing whether combining BL-B01D1, an experimental antibody-drug conjugate, with glecirasib, a targeted KRAS G12C inhibitor, can shrink tumors in adults with locally advanced or metastatic non-small cell lung cancer that carries a KRAS G12C mutation. The phase 2 …
Phase 2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can rituximab infusions keep scleroderma lungs stable?
Disease control Not yet recruitingResearchers test whether rituximab helps maintain lung function in adults with systemic sclerosis and interstitial lung disease whose disease has stabilized after initial rituximab treatment. Participants receive rituximab or placebo infusions at months 0, 6, and 12. The main mea…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a Patient's own airway stem cells repair damaged lungs in COPD?
Disease control Not yet recruitingResearchers are testing REGEND001, a therapy made from a patient's own airway basal stem cells, to see if it can improve lung function in people with chronic obstructive pulmonary disease (COPD) and emphysema. The trial enrolls adults aged 40 to 75 with moderate to severe COPD. P…
Phase 3 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a simple checklist help surgeons remove every last cancer cell?
Disease control Not yet recruitingResearchers are testing whether a shared checklist used during lung cancer surgery helps surgeons achieve cleaner, more complete tumor removal. The trial enrolls adults with early-stage non-small cell lung cancer who are scheduled for surgery. Half the participating hospitals use…
Sponsor: Fondation Hôpital Saint-Joseph • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Engineered immune cells take aim at deadly lung cancer
Disease control Not yet recruitingThis early-phase trial tests a new therapy for people with advanced small cell lung cancer or similar neuroendocrine cancers that have not responded to prior treatment. The approach involves collecting a patient's own immune cells, modifying them in a lab to recognize a protein c…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Experimental drug telaglenastat aims to lower lung blood pressure
Disease control Not yet recruitingThis study tests whether the drug telaglenastat, taken twice daily for 12 weeks, can safely lower blood pressure in the lungs and improve heart and lung function in adults with pulmonary hypertension. About 28 participants will receive the drug on top of their usual care. The mai…
Phase 1/2 • Sponsor: Chan, Stephen, MD, PhD • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could a shock drug help ARDS patients breathe easier?
Disease control Not yet recruitingThis study tests an experimental drug called centhaquine in 80 adults with moderate to severe ARDS, a life-threatening lung condition. The drug is added to standard care to see if it improves oxygen levels and reduces deaths. Participants must be in the ICU and start treatment wi…
Phase 2 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a smaller dose of this cancer drug still work? new trial aims to find out
Disease control Not yet recruitingThis phase 2 trial is testing whether a lower dose of the immunotherapy drug nivolumab, given less often, can still control cancer in people with various advanced or metastatic cancers. The goal is to see if a cheaper, more accessible regimen works as well as the standard high-co…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two antifungal pills go head to head against a fungus that scars the lungs
Disease control Not yet recruitingResearchers compare two oral antifungal medicines, itraconazole and posaconazole, in people with chronic pulmonary aspergillosis, a fungal infection that damages the lungs over time. The trial enrolls 220 adults who have not yet received antifungal treatment and assigns them to o…
Phase 3 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two-Drug combo takes aim at Hard-to-Treat lung cancer
Disease control Not yet recruitingResearchers are testing whether adding the immunotherapy adebrelimab to HS-20093 (risvutatug rezetecan) works better than HS-20093 alone in adults with advanced or metastatic non-squamous non-small cell lung cancer that has already been treated and has no actionable gene changes.…
Phase 2 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug combo takes aim at a Hard-to-Treat lung cancer mutation
Disease control Not yet recruitingResearchers are testing whether adding the experimental oral drug HS-10370 to platinum-based chemotherapy, with or without the immunotherapy adebrelimab, works better than tislelizumab plus chemotherapy. The trial enrolls about 448 adults with previously untreated, locally advanc…
Phase 3 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can zapping residual lung cancer spots extend remission?
Disease control Not yet recruitingResearchers are testing whether adding focused radiation to the few remaining cancer spots helps people with advanced EGFR-mutant non-small cell lung cancer live longer without their disease getting worse. Participants first receive a third-generation EGFR-targeted drug plus plat…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug RO7830698 put to the test for COPD
Disease control Not yet recruitingResearchers are testing an experimental drug called RO7830698 to see if it is safe and well tolerated. The trial includes healthy volunteers and people with chronic obstructive pulmonary disease (COPD). Participants receive either RO7830698 or a placebo, and researchers track sid…
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Antibody-Drug conjugate takes aim at c-Met-High lung cancer
Disease control Not yet recruitingResearchers are testing whether an experimental drug called telisotuzumab adizutecan works better than standard chemotherapy for people with non-squamous non-small cell lung cancer that has grown after earlier treatment. The trial enrolls about 660 participants whose tumors are E…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New study aims to cut pneumonia risk in HIV patients with smart medication checks
Disease control Not yet recruitingThis study tests whether a pharmacist-led electronic consultation can improve lung health for people with HIV who smoke or use certain medications that raise pneumonia risk. Pharmacists will review records and suggest changes like smoking cessation aids, vaccines, or stopping unn…
Sponsor: Seattle Institute for Biomedical and Clinical Research • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a targeted drug delivery system shrink lung tumors?
Disease control Not yet recruitingThis trial tests an experimental drug called TUB-040 in adults with advanced non-small cell lung cancer that cannot be removed with surgery or has spread. TUB-040 is designed to attach to a protein on cancer cells and deliver a toxic payload directly to the tumor, potentially kil…
Phase 2 • Sponsor: Tubulis GmbH • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a targeted pill be safely used for RET-Driven cancers in india?
Disease control Not yet recruitingResearchers are studying the safety of selpercatinib, an oral drug, in people in India with advanced cancers that have changes in the RET gene. The trial includes adults with RET fusion-positive non-small cell lung cancer and adults and children aged 12 and older with RET-mutant …
Phase 4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Two-Drug combo targets Hard-to-Treat recurrent small cell lung cancer
Disease control Not yet recruitingResearchers are testing a combination of paclitaxel polymeric micelles and ivonescimab in adults with small cell lung cancer that has returned or stopped responding after platinum-based chemotherapy and anti-PD-1/PD-L1 therapy. The phase 2 trial aims to see how many participants'…
Phase 2 • Sponsor: Shaodong Hong • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Two-Drug combo aims to shrink lung tumors before surgery
Disease control Not yet recruitingResearchers are testing whether giving toripalimab plus sacituzumab tirumotecan before surgery helps people with resectable non-small cell lung cancer. The trial enrolls about 30 adults with stage II to IIIB disease that has not been treated and lacks certain driver mutations. Pa…
Phase 2 • Sponsor: Shaodong Hong • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug takes aim at ROS1-Positive lung cancer in Head-to-Head trial
Disease control Not yet recruitingResearchers are comparing an experimental oral drug called JYP0322 with crizotinib in adults who have not yet received treatment for ROS1-positive locally advanced or metastatic non-small cell lung cancer. The phase III trial aims to see which drug keeps cancer from worsening lon…
Phase 3 • Sponsor: Guangzhou JOYO Pharma Co., Ltd • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Radiation and immunotherapy combo tested against advanced lung cancer
Disease control Not yet recruitingResearchers are testing whether adding stereotactic radiation to two drugs, envafolimab and endostar, helps people with stage IV non-small cell lung cancer. Participants have tumors without common EGFR, ALK, or ROS1 mutations and have not received prior systemic treatment. Everyo…
Phase 2 • Sponsor: The First People's Hospital of Lianyungang • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
COPD drug breztri under Real-World watch in korea
Disease control Not yet recruitingThis study will follow 600 adults in Korea who have been prescribed Breztri for COPD, a long-term lung disease. Researchers want to see how safe the drug is in everyday use and whether it works as expected. Participants will take Breztri as their doctor prescribes, and the study …
Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a Pharmacist's talk help COPD patients breathe easier and spend less?
Disease control Not yet recruitingResearchers at Buraidah Central Hospital in Saudi Arabia are testing whether a pharmacist-led educational program helps COPD patients take their medications as prescribed, enjoy a better quality of life, and lower their direct healthcare costs. The program uses the Health Belief …
Sponsor: Rabia Hussain • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New vaccine combo takes on tough lung cancer in early trial
Disease control Not yet recruitingThis early-phase study tests a new cancer vaccine (EVM14) combined with an immunotherapy drug (ivonescimab) in 13 people with advanced squamous non-small cell lung cancer that has not been treated before. The main goals are to check safety and find the right dose, while also look…
Phase 1 • Sponsor: Everest Medicines (Beijing) Co., Ltd. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New combo radiation approach aims to control advanced lung cancer
Disease control Not yet recruitingThis study tests whether giving high-precision radiation (SBRT) to the main tumor and nearby lymph nodes, along with standard chemotherapy, can better control stage III non-small cell lung cancer. The trial will enroll 20 adults whose tumors are less than 6 cm and who have not sp…
Sponsor: All India Institute of Medical Sciences • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can electric pulses destroy lung tumors without surgery?
Disease control Not yet recruitingThis trial tests a device that uses pulsed electric fields to destroy lung tumors. It is for people with early-stage non-small cell lung cancer or lung metastases that cannot be removed with surgery or treated with radiotherapy. Participants receive the ablation under general ane…
Sponsor: Energenx Medical LTD. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a guided missile for chemo hit tumors harder and spare healthy tissue?
Disease control Not yet recruitingResearchers are testing a new drug called TS-104 in adults with advanced solid tumors, including lung, head and neck, ovarian, endometrial, esophageal, and gastric cancers. TS-104 is a peptide drug conjugate: it uses a targeting peptide to carry the chemotherapy drug MMAE directl…
Phase 1 • Sponsor: TwoStep Therapeutics, Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a pharmacist and a phone app keep cancer patients on track with their other meds?
Disease control Not yet recruitingPeople newly diagnosed with breast, colorectal, lung, or prostate cancer often also manage other long-term conditions and take multiple medications. This pilot study tests whether a pharmacist-led medication review plus the Medisafe mobile app helps them stick to those regimens. …
Sponsor: Duke University • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can an oral drug that starves tumors help Hard-to-Treat cancers?
Disease control Not yet recruitingResearchers are testing an investigational oral drug called catequentinib hydrochloride (AL3818) in adults with advanced or metastatic endometrial cancer, low grade serous ovarian cancer, soft tissue sarcoma, or glioblastoma. The trial has two parts: a phase 1b part to find safe …
Phase 1/2 • Sponsor: Advenchen Pharmaceuticals, LLC. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New drug duo aims to tackle Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase study is testing a combination of two experimental drugs, Ris-Rez and ivonescimab, in about 184 adults with advanced solid tumors that have spread. The main goals are to find a safe dose, understand side effects, and see if the combo can shrink tumors. It's a fir…
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can one needle biopsy and freeze lung nodules in a single visit?
Disease control Not yet recruitingThis study tests whether a very thin freezing needle can safely biopsy and destroy suspicious lung nodules in one procedure. About 30 adults with small lung nodules who are not candidates for or decline surgery will undergo the combined approach under CT guidance. Researchers wil…
Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can an oral drug R01 fight advanced lung, stomach, and esophageal cancers?
Disease control Not yet recruitingThis early-phase trial tests an oral drug called R01 in people with advanced squamous cell lung cancer, gastric cancer, or esophageal cancer that has progressed after standard treatment. The study aims to find the safest dose and check whether R01 can shrink tumors. Participants …
Phase 1 • Sponsor: Beijing Anjianxi Bio-Medical Technology Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a common diabetes drug help fight a deadly lung disease?
Disease control Not yet recruitingThis study tests whether metformin, a standard diabetes medicine, can slow the worsening of idiopathic pulmonary fibrosis (IPF), a serious lung disease. About 400 high-risk patients will receive either metformin or a placebo. The goal is to see if metformin can delay death, hospi…
Phase 3 • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a new drug shrink tumors that resist standard care?
Disease control Not yet recruitingThis early-stage trial tests an experimental drug called STRO-006 in adults with advanced solid tumors, including head and neck, lung, esophageal, gastric, colorectal, endometrial, bladder, and breast cancers that have not responded to standard treatments. The study has three par…
Phase 1 • Sponsor: Sutro Biopharma, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a new drug shrink advanced solid tumors?
Disease control Not yet recruitingThis early-stage trial tests an investigational drug called ABBV-253 in adults with advanced solid tumors, including lung, colorectal, and pancreatic cancers. The study aims to find safe doses and see whether the drug can shrink tumors. Participants receive the drug by infusion, …
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can viruses that eat bacteria beat a deadly hospital lung infection?
Disease control Not yet recruitingThis trial tests whether inhaling bacteriophages, which are viruses that specifically kill Pseudomonas aeruginosa bacteria, can help clear a serious lung infection in patients on breathing machines. The study includes adults with ventilator-associated pneumonia caused by this bac…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new injection help COPD patients cut steroid use?
Disease control Not yet recruitingThis Phase 3 extension study evaluates the long-term safety and efficacy of lunsekimig, an injectable drug, in adults with COPD who completed earlier lunsekimig trials. Participants receive lunsekimig for up to 96 weeks, and a sub-study tests whether they can safely withdraw from…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New chemo combo shows promise for tough lung cancer
Disease control Not yet recruitingThis Phase 2 trial tests whether adding lurbinectedin to paclitaxel works better than paclitaxel alone for people with advanced small cell lung cancer that has returned after first treatment. About 69 adults will be randomly assigned to one of two groups. The study measures how m…
Phase 2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Inhaled therapy aims to slow the march of progressive pulmonary fibrosis
Disease control Not yet recruitingThis phase 3 trial tests an inhaled drug called treprostinil palmitil in adults with progressive pulmonary fibrosis, a condition where lung scarring worsens over time despite standard care. Participants inhale the drug or a placebo once daily for 52 weeks. Researchers measure whe…
Phase 3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a week at sea level ease strain on High-Altitude hearts?
Disease control Not yet recruitingThis trial studies people with pulmonary arterial hypertension (PAH) who live permanently above 2600 meters. Researchers want to see if spending one week at sea level and then returning to high altitude changes pressure in the lung's blood vessels. They will measure heart and lun…
Sponsor: Silvia Ulrich Somaini • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a targeted pill clear hidden lung cancer cells after surgery?
Disease control Not yet recruitingThis phase 2 trial tests whether zipalertinib, an oral drug that targets cancer cells with atypical EGFR mutations, can eliminate remaining cancer cells in people with early-stage non-small cell lung cancer. Participants who have completed standard treatment and show signs of min…
Phase 2 • Sponsor: Stanford University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New pill aims to halt lung scarring in thousands
Disease control Not yet recruitingThis study tests a drug called nerandomilast in 466 adults with fibrosing interstitial lung disease (ILD) who are at risk of worsening. Participants take either the drug or a placebo for at least 52 weeks. Doctors measure lung function and use CT scans to see if the drug slows di…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a coordinated care team reduce severe side effects in older cancer patients?
Disease control Not yet recruitingThis trial tests whether a coordinated care pathway, involving oncologists, geriatricians, pharmacists, and pharmacologists, can reduce severe side effects in adults over 70 with certain cancers who are starting oral therapy. Participants receive extra monitoring, including blood…
Phase 4 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a Two-Drug combo outperform standard care in aggressive lung cancer?
Disease control Not yet recruitingThis phase III trial compares an experimental combination of two drugs, QLC5508 and QL2107, against the current standard treatment (tislelizumab plus chemotherapy) as a first-line therapy for people with extensive-stage small cell lung cancer. The study enrolls adults who have no…
Phase 3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New trial aims to find best treatment for lung complication in rheumatoid arthritis
Disease control Not yet recruitingThis 52-week study will compare three drugs—tocilizumab, telitacicept, and methotrexate—in 204 people with rheumatoid arthritis who also have interstitial lung disease. The main goal is to see which drug best improves lung function. Participants will continue their usual arthriti…
Phase 4 • Sponsor: Chinese SLE Treatment And Research Group • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a Two-Drug combo keep Limited-Stage lung cancer at bay?
Disease control Not yet recruitingThis phase 2 trial tests whether combining an experimental drug called SHR-7787 with the immunotherapy adebrelimab can help people with limited-stage small cell lung cancer. The study enrolls adults aged 18 to 75 whose cancer has not progressed after standard chemotherapy and rad…
Phase 2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a two-drug combo outsmart resistant lung cancer?
Disease control Not yet recruitingThis phase 1 trial tests whether combining an experimental oral drug, JIN-A02, with an existing intravenous drug, amivantamab, is safe and can shrink tumors in people with advanced EGFR-mutant non-small cell lung cancer that has progressed after treatment with a third-generation …
Phase 1 • Sponsor: Yonsei University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Smart patch and app aim to boost lung recovery after cancer surgery
Disease control Not yet recruitingThis trial tests whether a wireless wearable monitor (chest patch or wristband) plus a smartphone-based rehab program can help people recover lung function after surgery for non-small cell lung cancer. Participants who have had curative-intent surgery will either receive standard…
Sponsor: West China Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Experimental drug duo aims to boost immune attack on tough cancers
Disease control Not yet recruitingThis study tests a combination of two experimental drugs, obrixtamig and ZL-1310, designed to help the immune system fight cancer. It is for adults with advanced small cell lung cancer or other neuroendocrine cancers. The trial has two parts: the first finds a safe dose of the tw…
Phase 1/2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a new ventilation mode keep lungs healthier after heart surgery?
Disease control Not yet recruitingThis trial tests whether a newer ventilation method, called flow-controlled ventilation, keeps the lungs and diaphragm in better shape than the standard pressure-controlled method during elective heart bypass surgery. About 154 adults scheduled for on-pump coronary artery bypass …
Sponsor: Koşuyolu Kartal Heart Training and Research Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can immune cell infusions help fight solid tumors?
Disease control Not yet recruitingThis trial tests a cell therapy called DC-CTL, made from a patient's own immune cells, combined with standard anti-tumor treatment. The goal is to see if this approach is safe and may help control solid tumors such as colorectal, esophageal, lung, liver, and breast cancer. About …
Sponsor: Zhengzhou Revo-Gene Technology Co., LTD • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New combo therapy targets hard-to-treat lung cancer mutation
Disease control Not yet recruitingThis study tests whether adding a cancer vaccine (CIMAVAX-EGF) to standard targeted drugs (sotorasib or adagrasib) can help control advanced lung cancer with a KRAS G12C mutation. About 29 adults with stage III or IV non-small cell lung cancer will receive the combination. The go…
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Wearable tech and digital rehab may shorten recovery between lung cancer surgeries
Disease control Not yet recruitingThis trial tests whether a digital rehabilitation program, combined with wireless wearable monitors, can help people recover faster between two planned lung cancer surgeries. Participants with multiple primary non-small cell lung cancer will be randomly assigned to either standar…
Sponsor: West China Hospital • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can radiation spare the brain while fighting cancer in the spinal fluid?
Disease control Not yet recruitingThis trial tests a type of radiation called brain-avoidant proton craniospinal irradiation (BRAVO-pCSI) in people with leptomeningeal metastases, a condition where cancer spreads to the fluid and lining around the brain and spinal cord. The study includes adults with breast cance…
Phase 2 • Sponsor: University of Miami • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Personalized exercise plans could boost COPD recovery
Disease control Not yet recruitingThis trial tests whether prescribing exercise based on a person's individual metabolic threshold, measured during a cardiopulmonary exercise test, improves outcomes more than the standard six-minute walk test approach. Researchers will compare exercise capacity, adherence, muscle…
Sponsor: Aveiro University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can adjusting breathing effort during ventilation improve lung function in ARDS?
Disease control Not yet recruitingThis trial tests how different levels of spontaneous breathing during a ventilation mode called APRV affect lung function in adults with moderate-to-severe acute respiratory distress syndrome (ARDS). Each participant receives three breathing conditions in random order: low, high,…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Smart mask alarms may spot breathing trouble before it turns critical
Disease control Not yet recruitingThis trial tests a new monitoring device, the Linshom CPRM, which fits into an oxygen mask or nasal cannula and alerts nurses when a patient's breathing starts to fail. Researchers will compare standard monitoring plus the Linshom alarm against standard monitoring alone in about …
Sponsor: Linshom Medical, Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New MRI technique aims to spare healthy lung during cancer radiation
Disease control Not yet recruitingThis early-phase trial tests whether a special MRI scan using hyperpolarized xenon gas can help doctors plan radiation treatment for non-small cell lung cancer. The goal is to deliver enough radiation to the tumor while avoiding healthy lung tissue, which could reduce side effect…
Phase 1/2 • Sponsor: Xemed LLC • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a new drug rally the immune system against Hard-to-Treat cancers?
Disease control Not yet recruitingThis early-stage trial tests an experimental medicine called BI 3822971 in adults with advanced or metastatic solid cancers, such as lung, head and neck, breast, esophageal, bladder, vulvar, or cervical cancer, who have no standard treatment options left. The goal is to find out …
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a week at sea level ease the strain of High-Altitude living on damaged lungs?
Disease control Not yet recruitingThis trial studies people with pulmonary arterial hypertension, a condition where high blood pressure strains the lungs, who live permanently above 2600 meters. Researchers test whether spending one week at sea level and then returning to altitude changes how far participants can…
Sponsor: Silvia Ulrich Somaini • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a smarter ventilator setting spare damaged lungs on ECMO?
Disease control Not yet recruitingThis pilot trial tests a ventilator strategy that targets a specific measure of lung stress, called mechanical power, in adults with severe ARDS who are on VV ECMO. The goal is to see if this approach is feasible and safe compared to standard ultra-low tidal volume ventilation. R…
Sponsor: University of Virginia • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Ancient remedies put to the test against pneumonia in the elderly
Disease control Not yet recruitingThis study follows over 2,000 elderly patients hospitalized with community-acquired pneumonia to see whether adding traditional Chinese medicine (TCM) to standard care improves recovery. Researchers will compare patients who receive TCM with those who do not, tracking hospital st…
Sponsor: Henan University of Traditional Chinese Medicine • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a smart oxygen device outperform manual care in recovery?
Disease control Not yet recruitingThis trial tests whether an automated oxygen titration system, called FreeO2, can improve oxygen weaning in patients recovering from acute hypoxemic respiratory failure. The device continuously adjusts oxygen flow based on oxygen saturation levels, potentially reducing episodes o…
Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Experimental drug aims to improve breathing in lung sarcoidosis
Disease control Not yet recruitingThis study tests an investigational drug called XTMAB-16 in people with pulmonary sarcoidosis, a condition that causes inflammation and scarring in the lungs. The trial aims to see if the drug can improve lung function (measured by forced vital capacity) and quality of life. Part…
Phase 2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can matching drugs to biology beat ARDS?
Disease control Not yet recruitingThis trial tests whether two existing drugs, simvastatin and baricitinib, can help people with acute respiratory distress syndrome (ARDS), a severe lung condition that causes breathing failure. Participants are grouped by biological markers into subtypes, then randomly assigned t…
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a targeted drug combo outperform standard care for aggressive lung cancer?
Disease control Not yet recruitingThis phase 3 trial tests whether the experimental drug ZL-1310, when combined with an immunotherapy drug, can help people with extensive-stage small cell lung cancer live longer than those receiving standard chemotherapy plus immunotherapy. The study enrolls about 530 adults who …
Phase 3 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Which drug cuts COPD Flare-Ups better? a Head-to-Head test
Disease control Not yet recruitingThis trial tests two oral drugs, roflumilast and azithromycin, as add-on treatments for people with severe COPD and a chronic bronchitis pattern. About 70 adults will take one of the drugs daily for six months while continuing their usual inhaled therapy. The goal is to see which…
Phase 4 • Sponsor: Sidra Aziz • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Goat milk ladder may offer a new route to milk tolerance in allergic children
Disease control Not yet recruitingThis trial tests whether a four-step ladder made with goat milk formula helps children aged 1 to 5 with cow's milk allergy build tolerance to milk better than the standard cow's milk ladder. Both ladders start with baked goods and progress to plain milk over 12 weeks, with each s…
Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a common steroid tame severe flu in the ICU?
Disease control Not yet recruitingThis phase III trial asks whether giving dexamethasone early to adults with severe influenza pneumonia and low blood oxygen can improve outcomes. Participants in intensive or intermediate care receive either the steroid or a placebo for up to 10 days, alongside standard flu treat…
Phase 3 • Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can Real-Time lung imaging Fine-Tune ventilator care for ARDS?
Disease control Not yet recruitingThis trial tests whether using electrical impedance tomography (EIT) to guide ventilator pressure settings improves lung function in patients with moderate-to-severe acute respiratory distress syndrome (ARDS) who are placed face down (prone positioning). Researchers will compare …
Sponsor: XIE MIN • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can varying breath size protect lungs on a ventilator?
Disease control Not yet recruitingThis trial tests whether a ventilator method called variable ventilation, which changes the size of each breath slightly, is safe and feasible for adults with acute respiratory distress syndrome (ARDS) who need breathing support. Participants receive 24 hours of variable ventilat…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
A new twist on lung rehab: helping the helpers
Disease control Not yet recruitingThis trial tests a new approach to pulmonary rehabilitation, a standard programme of exercise and education for people with chronic lung disease. The twist is that informal carers, often family members, join the education and support sessions. The goal is to see if this carer-inc…
Sponsor: Aveiro University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Drones may rush donor lungs to transplant patients, saving precious time
Disease control Not yet recruitingThis trial tests whether a long-range drone can carry donor lungs from one city to another for people with end-stage lung disease awaiting a transplant. Researchers will measure the total door-to-door transport time and compare it with ground transport estimates. They will also t…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug cocktail aims to tame rare lung cancer
Disease control Not yet recruitingThis study tests whether adding a new drug, obrixtamig, to standard chemotherapy can help people with a rare and aggressive lung cancer called large-cell neuroendocrine carcinoma (LCNEC). The trial will include 75 adults with advanced LCNEC that cannot be cured by surgery. Resear…
Phase 2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a Two-Drug chemo combo outsmart resistant tumors?
Disease control Not yet recruitingThis early-stage trial is testing whether combining two chemotherapy drugs—liposomal irinotecan and cisplatin—can safely shrink or control advanced solid tumors that have not responded to standard treatments. The study will enroll about 44 adults aged 20 to 85 with various types …
Phase 1 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Exercise as a cancer ally: could a bike ride supercharge immunotherapy?
Disease control Not yet recruitingThis trial tests whether a structured exercise program can strengthen the immune system's attack on non-small cell lung cancer. Patients receiving chemo-immunotherapy before surgery will either follow an exercise plan with a stationary bike or receive standard recommendations. Th…
Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Less may be more: smaller lung surgery tested against standard for early cancer
Disease control Not yet recruitingThis phase 3 trial compares two surgical approaches for early-stage non-small cell lung cancer with small (≤2 cm), solid-dominant tumors located deep within the lung. One group receives segmentectomy, which removes only the affected segment of the lung, while the other receives l…
Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a new injection ease COPD and cut Flare-Ups?
Disease control Not yet recruitingThis trial is testing an investigational drug called brenipatide in adults with moderate-to-severe COPD. Participants will receive either brenipatide or a placebo for about a year, alongside standard care. The goal is to see if brenipatide improves lung function and reduces the n…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Weight-Loss drug may rescue lung cancer treatment from metabolic side effects
Disease control Not yet recruitingThis trial tests whether tirzepatide, a medication used for weight management, can reduce the rapid weight gain and metabolic changes caused by lorlatinib, a targeted therapy for ALK-positive non-small cell lung cancer. Adults already taking lorlatinib will receive weekly tirzepa…
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a Direct-to-Brain chemo route outsmart resistant lung cancer?
Disease control Not yet recruitingThis phase II trial is testing whether giving the chemotherapy drug thiotepa directly into the spinal fluid—via a small device called an Ommaya reservoir—can help control cancer that has spread to the lining of the brain and spinal cord (leptomeningeal metastases) in people with …
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a smartphone app replace hospital rehab for lung disease?
Disease control Not yet recruitingThis trial tests whether a digital rehabilitation programme called I-IMPACT can be a practical alternative to traditional centre-based pulmonary rehabilitation for adults with interstitial lung disease (ILD). The study will compare the two approaches, focusing on feasibility—such…
Sponsor: University Hospitals, Leicester • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Spinal zaps could reboot breathing after brain injury
Disease control Not yet recruitingThis trial tests whether epidural spinal cord stimulation can help people with severe brain injury breathe without a ventilator. Ten patients with stroke or traumatic brain injury who need mechanical ventilation will receive a surgically implanted electrode that delivers electric…
Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Lung cancer breakthrough: could observation replace surgery?
Disease control Not yet recruitingThis pilot study tests whether it is safe and feasible to skip surgery in patients with stage II-III non-small cell lung cancer who have a complete response to chemotherapy and immunotherapy. Fourteen participants will be randomly assigned to either observation or standard surger…
Phase 1 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Zapping resistant spots: radiation may buy more time for lung cancer patients on targeted drugs
Disease control Not yet recruitingThis study tests whether precisely targeted radiation (SBRT) can stop or slow the growth of a few resistant spots in metastatic lung cancer patients who are already on targeted therapy (TKI). About 60 adults with EGFR or ALK mutations will receive radiation to those spots, and do…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Blood test may tailor lung cancer immunotherapy, sparing unnecessary treatment
Disease control Not yet recruitingThis trial is testing whether a blood test that detects cancer DNA can guide the use of durvalumab, an immunotherapy, after standard chemoradiotherapy in patients with stage III lung cancer that cannot be removed by surgery. The goal is to see if giving durvalumab only to patient…
Phase 2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Poop pills may help revive immunotherapy in lung cancer patients
Disease control Not yet recruitingThis study tests whether a fecal microbiota transplant (FMT) — transferring healthy gut bacteria from a donor — can help restore the immune system's ability to fight advanced non-small cell lung cancer in 15 patients whose disease worsened after prior immunotherapy. Participants …
Phase 2 • Sponsor: Se-Hoon Lee • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a new painkiller prevent breathing crises after surgery?
Disease control Not yet recruitingThis study looks at whether a newer opioid painkiller, oliceridine, is less likely than the standard sufentanil to cause breathing problems after surgery in people at high risk of obstructive sleep apnea. About 851 adults with known or suspected sleep apnea will receive one of th…
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a simple color change improve breathing support for preemies?
Disease control Not yet recruitingThis trial tests whether using a colorimetric carbon dioxide (CO₂) detector to guide non-invasive breathing support (ventilation) improves care for premature infants born before 32 weeks. The detector changes color to show how well the baby is exhaling CO₂, which may help doctors…
Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a biologic clear the clogged airways of COPD?
Disease control Not yet recruitingThis study tests whether mepolizumab, an injectable medication, can improve lung ventilation and reduce mucus plugs in adults with COPD who have elevated eosinophils. Participants receive mepolizumab every 4 weeks for 48 weeks and undergo MRI and CT scans along with breathing tes…
Phase 4 • Sponsor: Western University, Canada • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a diabetes drug rebuild lungs and muscle in COPD?
Disease control Not yet recruitingThis pilot trial tests whether tirzepatide, a once-weekly injection used for diabetes and weight loss, can improve lung function and muscle health in overweight adults with COPD. About 30 participants will receive either tirzepatide or standard care for 12 months, with tests meas…
Phase 2 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Blood test may let cancer patients take safe breaks from immunotherapy
Disease control Not yet recruitingThis trial investigates whether a sensitive blood test (Signatera) can detect when it is safe to pause immunotherapy in people with advanced solid tumors like lung cancer, melanoma, and colorectal cancer. Participants are randomly assigned to either continuous standard immunother…
Sponsor: Natera, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a targeted radiation boost slow advanced lung cancer?
Disease control Not yet recruitingThis trial is testing whether giving radiotherapy to the main lung tumour, in addition to standard chemotherapy or immunotherapy, can reduce cancer spread and help people with metastatic non-small-cell lung cancer live longer. Around 420 adults with newly diagnosed stage IV lung …
Phase 3 • Sponsor: Trans Tasman Radiation Oncology Group • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can Real-Time MRI make radiation safer for Ultra-Central lung tumors?
Disease control Not yet recruitingThis trial tests whether MRI-guided stereotactic body radiotherapy (SBRT) can safely treat ultra-central lung tumors—growths located near the windpipe and major airways. Using an MR-LINAC machine, doctors can adjust the radiation beam in real time as the patient breathes, potenti…
Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Ancient herbs vs. superbugs: can TCM prevent repeat pneumonia?
Disease control Not yet recruitingThis study follows over 500 hospitalized adults with drug-resistant bacterial pneumonia to see whether those who receive systemic traditional Chinese medicine (such as herbal decoctions or injections) have fewer lower respiratory tract infections in the six months after leaving t…
Sponsor: Henan University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a new daily pill slow lung scarring in IPF?
Disease control Not yet recruitingThis phase 2 trial tests whether an experimental drug called HSK50042 can improve lung function in adults with idiopathic pulmonary fibrosis (IPF), a chronic condition that causes lung scarring and breathing difficulties. Participants take HSK50042 or a placebo once daily for 26 …
Phase 2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a gentler drug trio tame small cell lung cancer in older patients?
Disease control Not yet recruitingThis trial is testing a combination of three drugs—benmelstobart, anlotinib, and etoposide—as a first treatment for elderly patients (65 and older) or those too frail for standard intensive chemotherapy. The goal is to see if this platinum-free regimen can control the cancer and …
Phase 3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Simple breathing device may speed recovery from a deadly sickle cell complication
Disease control Not yet recruitingThis trial investigates whether continuous positive airway pressure (CPAP) can help adults with sickle cell disease recover faster from acute chest syndrome, a serious lung complication. Participants who need extra oxygen are randomly assigned to receive either standard oxygen al…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could chemo plus immunotherapy double the punch against tough lung cancers?
Disease control Not yet recruitingThis phase 3 trial investigates whether adding platinum-based chemotherapy to the immunotherapy drug tislelizumab helps people with a specific type of advanced lung cancer live longer without the disease worsening. Participants have non-small cell lung cancer that has spread, sho…
Phase 3 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Blood test may spare lung cancer patients from chemo
Disease control Not yet recruitingThis study tests whether a blood test can identify people with advanced lung cancer who can be treated with immunotherapy alone instead of chemotherapy plus immunotherapy. The trial enrolls 275 adults with high PD-L1 levels and a low inflammation blood score. The goal is to see i…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can High-Flow oxygen through a tracheostomy speed ventilator weaning?
Disease control Not yet recruitingThis trial compares two oxygen methods for tracheostomized patients who are being weaned off a mechanical ventilator. Half receive high-flow oxygen directly into the tracheostomy tube, while the other half receive conventional oxygen. The goal is to see if high-flow oxygen helps …
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Smart cancer therapy: tailoring lung cancer treatment with a simple blood test
Disease control Not yet recruitingThis trial investigates a personalized approach for people with advanced EGFR-mutant non-small cell lung cancer who have not had prior treatment. Participants first take the targeted pill befotertinib for three weeks, then a blood test checks for minimal residual disease (MRD). T…
Phase 2 • Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a 7-Day antibiotic course be as effective as 14 days for COPD attacks?
Disease control Not yet recruitingThis trial investigates whether a 7-day course of antibiotics works as well as the standard 14-day course for adults hospitalized with a sudden worsening of COPD. The study involves over 500 participants and measures clinical success at 30 days, including symptom improvement and …
Sponsor: Capital Development Authority (CDA) Hospital Islamabad • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Tiny activity 'Snacks' may sharpen minds in COPD
Disease control Not yet recruitingThis study tests a program called Snacktivity, which involves doing very short bursts of moderate exercise—like brisk walking for 2 to 5 minutes, several times a day—to see if it can improve thinking skills and the ability to manage daily health in people aged 60 and older with C…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Home monitoring device aims to cut COPD hospitalizations by catching flare-ups early
Disease control Not yet recruitingThis trial tests whether a telemonitoring device called HCAlert can reduce hospitalizations and emergency visits for people with chronic obstructive pulmonary disease (COPD). Participants use the device at home to regularly measure their health, allowing doctors to spot worsening…
Sponsor: Hope Care, S.A • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could adding chemo to tarlatamab overcome resistance in lung cancer?
Disease control Not yet recruitingThis phase 2 trial is testing whether giving platinum-based chemotherapy (carboplatin and etoposide) together with the immunotherapy tarlatamab can help patients with advanced small-cell lung cancer whose disease has worsened while on tarlatamab alone. The study enrolls about 54 …
Phase 2 • Sponsor: University of Cologne • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug combo aims to outsmart lung cancer that resists immunotherapy
Disease control Not yet recruitingThis trial tests a combination of two drugs—tislelizumab and SYS6010—in people with advanced non-small cell lung cancer (NSCLC) whose cancer has progressed after immunotherapy. Tislelizumab is an approved immunotherapy, and SYS6010 is an experimental drug that targets EGFR on can…
Phase 1 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Heart attack without blockage: trial tests gentler blood thinners for SCAD
Disease control Not yet recruitingThis trial tests whether a less intensive antiplatelet therapy is safer and as effective as standard dual therapy for people with spontaneous coronary artery dissection (SCAD), a rare cause of heart attack in women aged 30–55. Unlike typical heart attacks, SCAD involves a tear in…
Phase 4 • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Surgical fix for failed lung valve treatment shows promise in early trial
Disease control Not yet recruitingThis trial investigates a surgical procedure to divide the fissure between lung lobes in people with COPD and emphysema who did not improve after endobronchial valve treatment. The goal is to see if the surgery is safe and feasible, potentially leading to better lung collapse and…
Sponsor: Rocco Bilancia • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New ventilation strategy aims to reduce lung damage in severe pneumonia
Disease control Not yet recruitingThis study tests a new way of using a breathing machine (ventilator) called time-controlled adaptive ventilation (TCAV) in people with severe lung injury from pneumonia. The goal is to see if TCAV reduces fluid buildup in the lungs compared to standard ventilation. The trial invo…
Sponsor: Central Hospital, Nancy, France • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Smart breathing machines at home could cut hospital visits for COPD patients
Disease control Not yet recruitingThis study looks at whether adding a home telemonitoring system to standard nighttime breathing support (non-invasive ventilation) can help people with severe COPD and high carbon dioxide levels. About 92 participants will be split into two groups: one using standard home ventila…
Sponsor: Air Liquide Healthcare Spain • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could an asthma drug help fight lung cancer? early trial investigates
Disease control Not yet recruitingThis pilot study tests whether an inhaled drug called cromolyn sodium, already used for asthma, is safe and feasible for people with locally advanced lung cancer. The drug works by calming mast cells, which may play a role in tumor growth and treatment resistance. About 5 to 10 p…
Phase 1 • Sponsor: Carcinex Inc • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Herbal mix and cancer drug join forces to fight fluid in lungs
Disease control Not yet recruitingThis study tests whether adding a Chinese herbal formula (Xuanyin Ning) to a standard cancer drug (bevacizumab) can better control malignant pleural effusion—fluid buildup in the chest caused by advanced lung cancer. About 308 participants will receive either the herbal formula o…
Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Triple attack on lung scarring: could plasma exchange and immune therapy slow IPF?
Disease control Not yet recruitingThis Phase II trial tests whether a combination of therapeutic plasma exchange (filtering the blood), rituximab (a drug that targets certain immune cells), and intravenous immunoglobulin (IVIg) can slow lung decline in people with progressive idiopathic pulmonary fibrosis (IPF). …
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New clinic aims to cut COPD Flare-Ups in half
Disease control Not yet recruitingThis study tests whether a dedicated clinic for COPD flare-ups can reduce the number of future attacks and improve quality of life. About 240 people who recently had a severe COPD attack will be split into two groups: one gets follow-up at the special clinic, the other gets stand…
Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New pill aims to cut lung infections in bronchiectasis patients
Disease control Not yet recruitingThis phase 3 trial tests whether a daily tablet called florensocatib can reduce the number of lung flare-ups in people with bronchiectasis, a chronic lung condition. About 904 participants aged 12 to 85 will be randomly assigned to receive either the drug or a placebo for up to 7…
Phase 3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Lung patients may soon do rehab from home via app
Disease control Not yet recruitingThis study tests whether a 12-week tele-pulmonary rehabilitation program, done at home via an app with a physiotherapist, helps people with chronic lung diseases start and stick with rehab better than going to a center. 90 patients will be randomly assigned to either remote rehab…
Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Inhaled mRNA therapy takes on solid tumors in first human trial
Disease control Not yet recruitingThis early-phase study tests an inhaled mRNA immunotherapy for adults with advanced lung cancer or solid tumors that have spread to the lungs. The treatment is given as a dry powder through an inhaler. The main goal is to check safety and find the best dose, with 60 participants …
Early phase 1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Sauna therapy could slash antibiotic use in chronic lung disease
Disease control Not yet recruitingThis study tests whether frequent sauna baths can reduce or eliminate bacteria that cause stubborn lung infections in people with conditions like COPD, asthma, or bronchiectasis. Researchers will track how long participants go without needing antibiotics and whether the bacteria …
Sponsor: Chronic Obstructive Pulmonary Disease Trial Network, Denmark • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New suction device aims to cut pneumonia risk in stroke patients
Disease control Not yet recruitingThis study tests a specially designed suction tube that cleans deep throat secretions under direct laryngoscope guidance. The goal is to see if it reduces pneumonia within 28 days in stroke patients who have trouble swallowing or coughing. Participants are adults with acute ische…
Sponsor: Shanghai Pudong New Area Gongli Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill targets Hard-to-Treat cancers in early trial
Disease control Not yet recruitingThis early-phase study tests an oral drug called SNH-118110 in 240 adults with advanced solid tumors that have a specific genetic change (RET). The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants must have tried other treatm…
Phase 1 • Sponsor: ScinnoHub Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Shorter antibiotic course may be just as effective for kids with pneumonia
Disease control Not yet recruitingThis study tests whether a 3-day course of amoxicillin works as well as a 5-day course for children aged 3 months to 5 years with uncomplicated pneumonia. The goal is to see if shorter treatment can reduce side effects, lower costs, and fight antibiotic resistance. About 250 chil…
Early phase 1 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for high altitude emergencies: study tests Life-Saving treatments
Disease control Not yet recruitingThis study aims to improve treatment for severe high altitude pulmonary edema (fluid in the lungs) and cerebral edema (brain swelling). Researchers will test breathing support devices and inhaled nitric oxide gas in over 3,000 patients in Tibet. The goal is to speed up recovery, …
Sponsor: Tibet Autonomous Region People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a gut bacteria pill help ARDS patients breathe easier?
Disease control Not yet recruitingThis early-stage trial tests R-3750, a live biotherapeutic product, in 20 adults with late-stage acute respiratory distress syndrome (ARDS). The main goal is to see if it is safe and tolerable, while also checking for signs of improved lung function and less need for a ventilator…
Phase 1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a COVID shot help fight lung cancer? new trial aims to find out.
Disease control Not yet recruitingThis study tests whether giving a Pfizer-BioNTech COVID-19 mRNA vaccine before standard immunotherapy (pembrolizumab) and chemotherapy can improve outcomes for people with stage 4 non-small cell lung cancer. Researchers will enroll 500 adults to see if the vaccine helps the immun…
Phase 2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug cocktail aims at resistant lung cancer
Disease control Not yet recruitingThis phase 2 trial tests whether combining two drugs, lomustine and anlotinib, can shrink tumors or slow disease in people with extensive-stage small cell lung cancer that has not responded to at least two prior treatments. About 46 participants will receive the drug combination …
Phase 2 • Sponsor: Yayi He • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Inhaled therapy aims to cut lung Tumors' sugar supply
Disease control Not yet recruitingThis pilot study tests whether an inhaled drug called AER101 can reduce glycolysis—the process cancer cells use to break down sugar for energy—in early-stage non-small cell lung cancer. Participants inhale the drug three times daily for two weeks before their scheduled surgery. T…
Early phase 1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug combo aims to keep lung cancer at bay longer
Disease control Not yet recruitingThis study tests whether adding tarlatamab to durvalumab after standard chemotherapy and radiation can delay cancer return and extend life in people with limited-stage small cell lung cancer. Tarlatamab works by helping immune cells recognize and attack cancer cells. About 430 pa…
Phase 3 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Electric belly zaps may help spinal cord injury patients cough better
Disease control Not yet recruitingThis study tests whether a device that electrically stimulates the abdominal muscles can improve cough strength in 150 adults with a recent spinal cord injury. Participants will use the device during breathing exercises for up to 6 weeks. The goal is to see if it helps clear mucu…
Sponsor: Liberate Medical • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New hope for lung cancer patients: drug combo targets tough tumors
Disease control Not yet recruitingThis study tests a new combination of two drugs (becotatug vedotin and pucotenlimab), with or without radiation, as a first treatment for people with advanced non-small cell lung cancer that has a specific protein (EGFR) on its surface. About 39 participants will receive the drug…
Phase 2 • Sponsor: Anhui Provincial Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Smart ventilator settings may cut Post-Surgery lung failure
Disease control Not yet recruitingThis study tests a new method for setting ventilators during abdominal surgery to prevent postoperative respiratory failure. The approach adjusts settings based on 'mechanical power,' a measure that combines several ventilator parameters. The trial will enroll 490 adults having a…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
500 patients to test if daily azithromycin keeps bronchiectasis attacks at bay
Disease control Not yet recruitingThis study tests whether taking a low dose of the antibiotic azithromycin every day for a year can reduce the number of serious lung infection flare-ups in adults with non-CF bronchiectasis. About 500 participants will receive either azithromycin or a placebo pill, added to their…
Phase 4 • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New formula aims to help Milk-Allergic babies keep food down
Disease control Not yet recruitingThis study tests whether a special anti-regurgitation formula, made from extensively hydrolysed casein, is safe and well-tolerated in infants with cow's milk protein allergy (CMPA). About 55 babies aged 1 to 9 months will take part. The formula is given in a controlled food chall…
Sponsor: Lactalis • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo aims to fight resistant lung cancer
Disease control Not yet recruitingThis Phase 3 trial tests whether adding an experimental drug called SYS6010 to the standard treatment osimertinib can help people with a specific type of advanced lung cancer (EGFR-mutant NSCLC) live longer without their cancer getting worse. About 680 participants will be random…
Phase 3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a common nausea drug shield ARDS lungs from further harm?
Disease control Not yet recruitingThis study tests whether ondansetron, a drug typically used for nausea, can reduce the strong urge to breathe in patients with acute respiratory distress syndrome (ARDS) who are on a ventilator. By lowering this drive, the drug may prevent patients from overworking their lungs an…
Phase 2/3 • Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can dupilumab keep COPD patients out of the hospital?
Disease control Not yet recruitingThis study tests whether adding dupilumab to standard COPD treatment can prevent another flare-up or hospital stay within 90 days. About 754 adults who were recently hospitalized for a COPD exacerbation will receive either dupilumab or a placebo. The goal is to see if the drug re…
Phase 4 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New study tests best way to give muscle relaxants for severe lung failure
Disease control Not yet recruitingThis study looks at how to best give muscle relaxants to patients with severe lung failure (ARDS) who are on a breathing machine. It compares giving the drug as a steady drip versus as separate shots. The goal is to see which method is safer and works better, and to plan a larger…
Phase 2 • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New digital toolkit aims to transform care for millions with multiple chronic diseases
Disease control Not yet recruitingThis study is for adults aged 40 and older who have two or more chronic conditions like high blood pressure, diabetes, or depression. Researchers are testing a program that includes a digital decision-support system for doctors, telemedicine for specialist advice, and a mobile ap…
Sponsor: Centre for Chronic Disease Control, India • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug duo aims to help lung fibrosis patients breathe easier
Disease control Not yet recruitingThis study tests whether adding nerandomilast to the standard drug mycophenolate is safe and tolerable for people with pulmonary fibrosis (lung scarring). About 120 adults with various types of lung fibrosis will take the combination for 4 months. The main goal is to see how many…
Phase 4 • Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a common antioxidant boost chemo for advanced lung cancer?
Disease control Not yet recruitingThis study tests whether adding alpha lipoic acid (a strong antioxidant) to standard chemotherapy helps people with advanced non-small cell lung cancer. About 60 adults with stage III or IV lung cancer will take 600 mg of alpha lipoic acid daily alongside their chemo. Researchers…
Phase 2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New lung device aims to calm COPD symptoms
Disease control Not yet recruitingThis study tests a device that targets nerves in the lungs to help people with moderate to severe COPD breathe easier. About 300 participants will be randomly assigned to receive the real treatment or a sham procedure. Researchers will track symptoms, exercise ability, and flare-…
Sponsor: Ryme Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New combo aims to turn untreatable lung tumors into surgical candidates
Disease control Not yet recruitingThis phase 2 trial tests whether combining the immunotherapy drug tislelizumab with standard chemotherapy and a targeted chemo-blocking procedure (BACE) can shrink advanced, inoperable stage III non-small cell lung cancer enough to allow surgery. About 39 participants will receiv…
Phase 2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New pill could boost breathing in COPD patients already on inhalers
Disease control Not yet recruitingThis study tests whether adding the drug doxofylline to standard inhaler therapy can improve lung function in people with stable COPD. 78 participants will take doxofylline or a placebo for 4 weeks, then switch. The main goal is to see if doxofylline increases the amount of air t…
Phase 4 • Sponsor: University of Milan • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New cocktail of immunotherapy, targeted drug, chemo, and radiation takes on lung cancer
Disease control Not yet recruitingThis phase 2 trial is testing a powerful combination of treatments for people with limited-stage small cell lung cancer (LS-SCLC) who have not had prior therapy. Participants will receive an immunotherapy drug (benmelstobart), an anti-angiogenic pill (anlotinib), standard chemoth…
Phase 2 • Sponsor: Yayi He • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New hope for advanced lung cancer: combo therapy targets tough tumors
Disease control Not yet recruitingThis study tests a new treatment for people with extensive-stage small cell lung cancer (ES-SCLC) who haven't had treatment before. It combines an immunotherapy drug (benmelstobart), a targeted therapy (anlotinib), and chemotherapy, followed by chest radiation. The goal is to see…
Phase 2 • Sponsor: Yayi He • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New lung-saving strategy aims to cut deadly ARDS complications
Disease control Not yet recruitingThis study tests a new way to use breathing machines for people with severe lung failure (ARDS). The goal is to reduce lung damage by using very gentle breaths and adding a machine that helps remove carbon dioxide from the blood. About 290 adults on breathing machines for less th…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Freeze and fry: new device tackles lung cancer in one procedure
Disease control Not yet recruitingThis study tests a device that uses both cold and radiofrequency to treat lung tumors during a standard bronchoscopy. Twenty people with early-stage lung cancer will receive the treatment before surgical removal of the tumor. The goal is to see if the device can safely and effect…
Sponsor: Elisabethinen Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Robot combines detection, biopsy, and ablation for lung cancer in single session
Disease control Not yet recruitingThis early study tests a robotic bronchoscopy system that aims to detect, sample, and treat small lung tumors in a single procedure. About 30 adults with suspicious lung nodules up to 3 cm who cannot or choose not to have surgery will participate. The system uses advanced imaging…
Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug duo aims to shrink tough lung cancer in 33-patient trial
Disease control Not yet recruitingThis study tests a combination of two drugs, sacituzumab tirumotecan and anlotinib, in people with extensive-stage small cell lung cancer whose cancer has already been treated. The goal is to see if the combination can shrink tumors. About 33 adults aged 18 to 75 with good perfor…
Phase 2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug cocktail aims to boost immune attack on lung cancer
Disease control Not yet recruitingThis Phase 2 trial tests two drug combinations for people with a specific genetic mutation (EGFR) in advanced non-small cell lung cancer. One group receives amivantamab plus lazertinib as first treatment; the other gets amivantamab plus chemotherapy after previous treatment stopp…
Phase 2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can breathing exercises help women sickened by cooking smoke?
Disease control Not yet recruitingThis study tests whether a pulmonary rehabilitation program can improve exercise tolerance and quality of life in women with COPD caused by long-term exposure to biomass fuel smoke. Sixty women who have never smoked but used biomass fuels for cooking or heating will be randomly a…
Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a common numbing drug shield Babies' lungs after heart surgery?
Disease control Not yet recruitingThis study tests whether giving the numbing drug lidocaine during heart surgery can reduce lung damage in infants. 320 babies under 1 year old having heart surgery will receive either lidocaine or a placebo. The goal is to see if lidocaine lowers the severity of lung injury after…
Phase 4 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New pill aims to slow lung decline in scarring disease
Disease control Not yet recruitingThis Phase 3 trial tests whether HSK44459 tablets can slow the decline in lung function for adults with progressive pulmonary fibrosis, a condition where lung scarring worsens over time. About 378 participants will take the drug or a placebo twice daily for 52 weeks. The main goa…
Phase 3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug cocktail aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis phase II trial tests whether combining two drugs—sacituzumab tirumotecan and toripalimab—given before surgery can shrink tumors in people with stage II to IIIB non-small cell lung cancer (NSCLC). About 38 participants will receive the drugs intravenously over several weeks, …
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo therapy aims to outsmart drug-resistant lung cancer
Disease control Not yet recruitingThis study tests whether adding capivasertib to osimertinib can help people with a specific type of advanced lung cancer whose disease has worsened after initial treatment. About 53 adults with EGFR-mutant NSCLC and additional PIK3CA/AKT1/PTEN gene changes will receive the two dr…
Phase 1/2 • Sponsor: Shanxi Province Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug combo takes on rare, Drug-Resistant lung bug
Disease control Not yet recruitingThis trial tests a new combination of antibiotics (called Arm D) against standard treatments for a rare lung infection caused by Mycobacterium abscessus. About 300 people with or without cystic fibrosis will take part. The goal is to see if the new combo clears the infection bett…
Phase 2 • Sponsor: The University of Queensland • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New study aims to improve COPD care by checking the heart too
Disease control Not yet recruitingThis study tests whether adding a thorough heart evaluation to standard lung care helps people with mild-to-moderate COPD who also have heart risks. About 350 adults will be randomly assigned to either the combined heart-lung check or usual respiratory care. The goal is to see if…
Sponsor: University of Bari Aldo Moro • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Smart anesthesia machine may protect lungs in elderly surgery patients
Disease control Not yet recruitingThis study looks at whether using an automatic lung re-expansion feature on anesthesia machines can improve lung function and reduce complications in elderly patients (65+) after laparoscopic surgery. About 58 participants will be randomly assigned to receive either the automated…
Sponsor: Yongtao Sun • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could a bag CPAP device save lives in Low-Resource hospitals?
Disease control Not yet recruitingThis study tests whether a Bag CPAP device, added to standard oxygen, can reduce the need for breathing tubes in adults with acute hypoxemic respiratory failure. Researchers in Rwanda will randomly assign 250 patients to receive either Bag CPAP plus oxygen or oxygen alone. The ma…
Sponsor: Prof RWABIHAMA Jean Paul • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug cocktail targets hard-to-treat lung cancer before surgery
Disease control Not yet recruitingThis phase 2 trial tests a sequence of targeted therapy (garsorasib), immunotherapy (ivonescimab), and chemotherapy before and after surgery for people with a specific type of lung cancer (KRAS G12C mutation) that can be removed. The goal is to see if this approach increases the …
Phase 2 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a smart app tame childhood asthma?
Disease control Not yet recruitingThis study tests a digital health assistant called 'Alex' to help children and teens aged 10 to 19 with asthma. Over six months, the app tracks lung function, symptoms, and medication use, and later gives personalized advice. The goal is to see if it improves asthma control and m…
Sponsor: University Children's Hospital Basel • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New hope for lung cancer patients: experimental drug SYS6010 faces off against chemotherapy
Disease control Not yet recruitingThis Phase 3 trial compares an experimental drug called SYS6010 with the standard chemotherapy docetaxel in about 506 people with advanced non-squamous non-small cell lung cancer that has not responded to prior treatments. The study aims to see if SYS6010 can slow cancer growth o…
Phase 3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for rare lung disease: triple therapy trial launches
Disease control Not yet recruitingThis study tests whether a combination of three drugs (prednisone, azithromycin, and hydroxychloroquine) can slow lung function decline in adults with interstitial lung disease caused by certain gene variants. About 30 participants will receive either the triple therapy or standa…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Lung cancer showdown: surgery vs. radiation in High-Risk patients
Disease control Not yet recruitingThis study compares two treatments for high-risk patients with early-stage non-small cell lung cancer: minimally invasive surgery (wedge resection) and stereotactic body radiation therapy (SBRT). The goal is to see which approach leads to longer disease-free survival and better q…
Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New cocktail therapy aims to tackle Drug-Resistant lung cancer
Disease control Not yet recruitingThis phase 2 trial is testing whether a combination of the experimental drug QL1706, standard chemotherapy, and bevacizumab can shrink tumors in people with advanced non-squamous non-small cell lung cancer that has specific gene changes and has stopped responding to targeted ther…
Phase 2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Immunotherapy plus chemo aims to extend lives in tough lung cancer
Disease control Not yet recruitingThis phase 2 trial tests whether adding the immunotherapy drug cemiplimab to standard chemotherapy helps people with advanced squamous non-small cell lung cancer live longer. About 108 people who have not had prior treatment will receive the combination. The study is not yet recr…
Phase 2 • Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New breathing method could ease preemie lung care
Disease control Not yet recruitingThis study tests whether a new breathing support called Pressure Targeted High Flow works as well as standard CPAP in premature infants with breathing problems. About 78 babies born before 33 weeks will try each method for 24 hours. Researchers will monitor breathing, oxygen need…
Phase 2 • Sponsor: University of Texas at Austin • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Freeze and burn: new device targets lung cancer during bronchoscopy
Disease control Not yet recruitingThis study is testing a device called the HybridTherm® system, which uses freezing and radiofrequency heat to destroy small lung tumors during a routine bronchoscopy. The procedure is done before the patient's planned surgery to remove the tumor. The main goals are to see if the …
Sponsor: Carolin Steinack • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can a Head-Down tilt or ancient herbs save lives in severe pneumonia?
Disease control Not yet recruitingThis large trial in China will test two additional treatments for people with severe pneumonia who need a breathing machine. One group will have their bed tilted head-down for at least 12 hours a day. Another group will receive a traditional Chinese herbal formula. The goal is to…
Phase 4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New hope for tough lung cancer: drug combo targets tumors after first treatment fails
Disease control Not yet recruitingThis study tests a combination of two drugs, sacituzumab tirumotecan and anlotinib, in 30 people with extensive-stage small cell lung cancer whose disease got worse after initial chemotherapy plus immunotherapy. The goal is to see if the combo can shrink tumors or slow cancer gro…
Phase 2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Ultrasound-Guided breathing care may shorten NICU stays for infants
Disease control Not yet recruitingThis study tests whether using lung ultrasound to guide breathing treatments can help infants with respiratory failure leave the NICU sooner. About 64 newborns will be randomly assigned to either ultrasound-guided care or standard care. The goal is to see if this approach reduces…
Sponsor: Tufts Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug cocktail targets Hard-to-Treat lung cancer
Disease control Not yet recruitingThis study tests a combination of two drugs, SHR-A1811 and pertuzumab, in people with advanced non-small cell lung cancer that has HER2 mutations or overexpression and has worsened after at least one prior treatment. The goal is to see if this combo can shrink tumors or slow dise…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Probiotic pill could tame COPD Flare-Ups, early trial hopes
Disease control Not yet recruitingThis early-stage trial tests an oral probiotic called R-3750 in 27 people with mild-to-moderate COPD. The main goal is to see if it is safe and tolerable. Researchers will also check if it improves breathing and quality of life using a standard questionnaire. The study is not yet…
Phase 1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New study seeks best backup plan for deadly pneumonia in immunocompromised patients
Disease control Not yet recruitingThis study looks at which second-choice treatment works best for a serious lung infection called PCP when the usual antibiotic cannot be used due to allergies, side effects, or failure. About 416 adults with weakened immune systems (from HIV, transplants, cancer, or other causes)…
Phase 4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Heart attack survivors may get Anti-Inflammatory boost from diabetes drug
Disease control Not yet recruitingThis study tests whether dapagliflozin, a drug typically used for diabetes, can lower inflammation in the heart arteries of people who recently had a heart attack but do not have diabetes or heart failure. About 110 participants will receive either the drug plus standard care or …
Phase 4 • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could a cholesterol drug boost chemo in resistant lung cancer?
Disease control Not yet recruitingThis early-phase trial is for people with non-small cell lung cancer that has stopped responding to second-line treatment. Researchers will use a lab test on a patient's own tumor cells to pick the best chemotherapy drugs, then add the statin pitavastatin. The goal is to see if t…
Phase 1 • Sponsor: Chang Chen • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could a common anesthetic keep lung cancer from returning?
Disease control Not yet recruitingThis study tests whether giving the anesthetic lidocaine during lung cancer surgery can reduce the chance of the cancer coming back. About 1,400 patients will be randomly assigned to receive lidocaine or a placebo. They will be followed for three years to track cancer recurrence …
Sponsor: First Affiliated Hospital of Ningbo University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can a simple gas save lives in severe lung failure?
Disease control Not yet recruitingThis study tests whether adding inhaled nitric oxide (iNO) to standard care helps adults with moderate-to-severe acute respiratory distress syndrome (ARDS) survive longer. About 536 participants will be randomly assigned to receive iNO or a placebo through their ventilator. The m…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Shorter steroid course for severe PCP? new trial aims to find out
Disease control Not yet recruitingThis study looks at how long steroids should be given to adults with severe Pneumocystis pneumonia (PCP), a serious lung infection common in people with weakened immune systems. About 416 participants who improve within 10 days will either stop steroids early or continue for 21 d…
Phase 4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could black seed oil help kids with asthma breathe easier?
Disease control Not yet recruitingThis study tests whether adding black seed oil (Nigella sativa) to standard asthma medication can improve asthma control and lung function in children aged 6–18 with moderate persistent asthma. Ninety children will receive either a low or high dose of black seed oil capsules or a…
Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can a different antibiotic beat stubborn pneumonia in kids?
Disease control Not yet recruitingThis study compares two antibiotics—doxycycline and azithromycin—in 208 children aged 3 to 17 with pneumonia caused by Mycoplasma pneumoniae. The goal is to see if doxycycline stops fever faster and is safe, especially regarding tooth color changes. Participants take the medicine…
Phase 4 • Sponsor: Young June Choe • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Lung valves could starve Drug-Resistant TB cavities
Disease control Not yet recruitingThis study tests whether placing one-way valves in the lungs can shrink cavities caused by drug-resistant tuberculosis (TB) or nontuberculous mycobacteria (NTM) infections. The valves block airflow into the cavity, creating a low-oxygen environment that may slow or stop bacterial…
Sponsor: Azienda Ospedaliero-Universitaria Careggi • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New PET tracer aims to light up hidden cancer targets
Diagnosis Not yet recruitingResearchers are testing a new PET/CT imaging tracer called [68Ga]-LY4257529 that targets a protein called GRPR, which some cancers make in large amounts. The study includes up to 60 adults with breast cancer or other tumors known or suspected to express GRPR, such as prostate, ov…
Early phase 1 • Sponsor: Jewish General Hospital • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Radioactive tracer aims to light up hidden lung scarring
Diagnosis Not yet recruitingResearchers at Mayo Clinic are testing an investigational radioactive tracer called 68Ga-FAPI-46 to see how it distributes in the lungs of people with interstitial lung disease. About 10 participants with a clinical diagnosis of ILD and lung abnormalities on a recent CT scan rece…
Phase 1 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
App aims to catch a hidden radiotherapy side effect
Diagnosis Not yet recruitingRadiation pneumonitis is a lung inflammation that can appear weeks after radiotherapy for lung cancer, and patients may not link their symptoms to the earlier treatment. Researchers developed a smartphone app called PneumoCheck for patients to use at home, hoping it helps detect …
Sponsor: University Hospital Schleswig-Holstein • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Software aims to steer bronchoscopes more precisely in lung cancer checks
Diagnosis Not yet recruitingResearchers at Penn State University are testing three software innovations designed to improve bronchoscopy guidance during lung cancer evaluations. The study enrolls a small number of adults who are already scheduled for a clinical bronchoscopy to examine abnormal lung tissue o…
Sponsor: Penn State University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Inhaled xenon gas could reveal hidden lung vessel disease without catheter
Diagnosis Not yet recruitingResearchers are testing a noninvasive MRI technique that uses inhaled hyperpolarized xenon gas to measure lung function in adults with interstitial lung disease, pulmonary hypertension, and systemic sclerosis. The study includes about 51 participants, including healthy volunteers…
Phase 2 • Sponsor: Bastiaan Driehuys • Aim: Diagnosis
Last updated Sep 17, 2026 00:00 UTC
-
Radioactive antibody aims to light up hidden solid tumors
Diagnosis Not yet recruitingResearchers are testing a new imaging agent called 111In-TJD-31 that targets placental alkaline phosphatase (ALPP), a protein found on many solid tumor cells but rarely in healthy adult tissue. The study enrolls 8 participants: 2 healthy volunteers who give blood samples and 6 pa…
Phase 1 • Sponsor: Yong He • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
AI reads tumor slides to match cancer patients with trials
Diagnosis Not yet recruitingMany cancer trials require patients to have specific molecular markers, so researchers test large numbers of people to find the few who qualify. This study evaluates FATHOM, an AI system that reads clinical trial records and routine tumor slides to predict which patients carry th…
Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
AI trained to tell dangerous lung nodules from harmless ones
Diagnosis Not yet recruitingResearchers are testing artificial intelligence models that analyze CT scans to find lung nodules and estimate whether they are benign or malignant. The study enrolls adults who have at least one non-calcified lung nodule measuring 3 to 30 mm. Participants receive no drugs or pro…
Sponsor: Shanghai East Hospital • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
Can a simple ultrasound combo predict breathing failure before it happens?
Diagnosis Not yet recruitingBlunt chest trauma can lead to serious breathing problems, but current imaging tools have limits. This study tests whether adding a diaphragm ultrasound to the standard lung ultrasound helps doctors predict which patients will develop hypoxemic respiratory failure. Adults with is…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
A safer scan for tiny lungs: ultrasound may spot newborn pneumonia without radiation
Diagnosis Not yet recruitingResearchers at Assiut University are testing whether lung ultrasound can diagnose pneumonia in newborns as reliably as the standard chest X-ray. The study will enroll 100 infants in the neonatal intensive care unit who have a clinical diagnosis of pneumonia within their first 28 …
Sponsor: Assiut University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
A breath sniff could one day screen for lung cancer and more
Diagnosis Not yet recruitingResearchers are testing whether an electronic nose that analyzes exhaled breath can serve as a noninvasive prescreening tool for several diseases at once. The study plans to enroll up to 20,000 adults and will first standardize the breath-sampling procedure, then evaluate how wel…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
Could a gentler breath test replace the harsh blow for COPD diagnosis?
Diagnosis Not yet recruitingThis study tests whether newer breathing technologies, such as capnography and oscillometry, can diagnose COPD as accurately as the standard spirometry test. Spirometry requires forceful blowing, which can be uncomfortable. Researchers will compare these tests in 300 adults with …
Sponsor: University Hospital Southampton NHS Foundation Trust • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
Laser and AI join forces to spot aggressive lung cancer
Diagnosis Not yet recruitingThis trial tests whether a new imaging method, using femtosecond laser light and artificial intelligence, can accurately predict high-risk features in lung cancer, such as spread to lymph nodes. Researchers will compare the AI's predictions with actual pathology results from surg…
Sponsor: Shanghai Zhongshan Hospital • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
Can a tiny camera help doctors diagnose lung nodules more accurately?
Diagnosis Not yet recruitingThis trial tests whether adding a small probe called the Iriscope to standard bronchoscopy improves the diagnosis of lung nodules. Doctors usually guide the biopsy with real-time X-rays, but sometimes they cannot see the nodule directly. The Iriscope slides into the bronchoscope …
Sponsor: Erasme University Hospital • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
Laser and AI team up to spot lung cancer in minutes
Diagnosis Not yet recruitingThis trial tests whether a femtosecond laser imaging technique, combined with artificial intelligence, can accurately distinguish benign from malignant lung tissue in surgical specimens. Researchers will compare the AI-assisted diagnosis against standard pathology results. The st…
Sponsor: Shanghai Zhongshan Hospital • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
Can a bedside ultrasound predict a deadly sickle cell complication?
Diagnosis Not yet recruitingThis study tests whether a bedside lung ultrasound, done within six hours of arriving at the emergency department, can help diagnose acute chest syndrome in adults with sickle cell disease experiencing a vaso-occlusive crisis. Acute chest syndrome is a serious lung complication t…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Aug 26, 2026 00:00 UTC
-
A 5-Minute ultrasound could reveal how sick a Baby's lungs really are
Diagnosis Not yet recruitingThis study tests whether a quick, bedside ultrasound of the internal jugular vein in the neck can help tell how severe bronchiolitis is in infants aged 1 to 23 months. Researchers will measure how much the vein's diameter changes with breathing and compare that to standard clinic…
Sponsor: Eskisehir Osmangazi University • Aim: Diagnosis
Last updated Aug 23, 2026 00:00 UTC
-
Can a simple CT scan catch lung cancer earlier in kuwait?
Diagnosis Not yet recruitingThis pilot study will offer low-dose CT scans to about 500 high-risk smokers aged 50-80 in Kuwait to see if this screening approach is practical and acceptable. The goal is to measure how many people agree to screening, identify barriers, and evaluate the use of AI to help read t…
Sponsor: Sulaiman Khadadah • Aim: Diagnosis
Last updated Aug 19, 2026 00:00 UTC
-
New imaging tracer could spot hidden cancers and fibrosis in one scan
Diagnosis Not yet recruitingThis study tests a new imaging tracer called [18F]FAPI-74, which attaches to a protein found on cells in tumors and scarred or inflamed tissue. Researchers want to see if it can show these areas more clearly than current scans. About 770 adults with various cancers or non-cancer …
Phase 1/2 • Sponsor: Martin Huellner • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
Breath of discovery: simple test may sniff out lung cancer
Diagnosis Not yet recruitingThis pilot study explores whether a breath sample collected with the VosCryo device can provide enough cellular material to help diagnose advanced lung cancer. Researchers will compare breath samples from 12 people with late-stage lung cancer and 12 healthy relatives to see if th…
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
AI stethoscope aims to cut unnecessary antibiotics in kids with cough
Diagnosis Not yet recruitingThis study tests whether an AI-powered digital stethoscope can help health workers more accurately diagnose pneumonia in children aged 2 months to 5 years. 350 children with cough or breathing difficulty will be randomly assigned to standard care or care plus the AI stethoscope. …
Phase 4 • Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
Spinal fluid DNA test could personalize brain cancer therapy
Diagnosis Not yet recruitingThis study explores whether analyzing tumor DNA in cerebrospinal fluid can help doctors make better treatment decisions for people with malignant brain tumors or brain metastases from lung or breast cancer. Participants undergo a standard spinal tap or fluid collection, and the f…
Sponsor: Alireza Mansouri • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
AI could help doctors diagnose lung cancer faster during a bronchoscopy
Diagnosis Not yet recruitingThis study tests an artificial intelligence (AI) prototype designed to quickly evaluate tissue samples taken during a bronchoscopy, a procedure used to diagnose lung cancer. The AI analyzes microscope images of the samples to determine if they are adequate for diagnosis and wheth…
Sponsor: Azienda Ospedaliera di Rilievo Nazionale A.Cardarelli • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
New imaging agent could sharpen lung cancer detection
Diagnosis Not yet recruitingThis early-phase trial will test a new radioactive tracer called [68Ga]Ga-PentixaFor in 15 people with metastatic small cell lung cancer. The goal is to see if this PET-CT scan can find tumors as well as the standard FDG PET-CT scan, both at diagnosis and when the disease gets wo…
Early phase 1 • Sponsor: Institut Cancerologie de l'Ouest • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple CT scan catch lung cancer early in indian smokers?
Diagnosis Not yet recruitingThis study will check if low-dose CT scans can find lung cancer early in 1,716 high-risk smokers in India. Participants get a baseline scan, and if anything looks suspicious, they are referred to a team of specialists for follow-up. The goal is to see if this screening method wor…
Sponsor: All India Institute of Medical Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
New disposable freezing catheter could make lung biopsies simpler
Diagnosis Not yet recruitingThis study will test a new, disposable freezing catheter (Celsio) in 30 people who need a lung procedure. The catheter uses extreme cold to help diagnose or treat conditions like lung cancer and interstitial lung disease. Unlike current devices, it does not need a bulky console o…
Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval • Aim: Diagnosis
Last updated Jun 27, 2026 12:10 UTC
-
AI-Powered chest X-Rays could revolutionize lung cancer screening in latin america
Diagnosis Not yet recruitingThis study will enroll 2,000 people aged 50 or older in Mexico, Costa Rica, Colombia, and Argentina who are at high risk for lung cancer due to smoking, wood smoke exposure, family history, or COPD. Participants will get a chest X-ray analyzed by artificial intelligence and a low…
Sponsor: Latin American Consortium for the Lung Cancer Research • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Glow-in-the-dark dye could help doctors spot lung cancer during a scope exam
Diagnosis Not yet recruitingThis study tests whether a special dye, given before a bronchoscopy, can make lung tumors glow so doctors can see them more clearly. About 20 adults with a suspicious lung nodule or lymph node will receive the dye and then have a bronchoscopy with a special camera. The goal is to…
Phase 2 • Sponsor: University Medical Center Groningen • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
New MRI dye could spot brain tumors sooner in cancer patients
Diagnosis Not yet recruitingThis study tests whether a new MRI contrast agent, gadopiclenol, can detect brain metastases earlier than standard methods in 180 patients with advanced lung, breast, or skin cancer. Participants will receive screening brain MRIs to compare diagnosis timing and accuracy. The goal…
Phase 2 • Sponsor: University of Zurich • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New blood test may spot silica lung damage before symptoms appear
Diagnosis Not yet recruitingThis study tests whether a specific antibody in the blood, called anti-CD146, can help doctors diagnose lung diseases caused by breathing in silica dust at work. Silica exposure can lead to serious lung problems like scarring, inflammation, and cancer, but there is currently no s…
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
New blood test may predict lung surgery risks
Diagnosis Not yet recruitingThis study aims to see if a blood test, taken before lung cancer surgery, can predict which patients will develop serious lung complications afterward. Researchers will analyze immune cells and proteins in the blood of 100 adults undergoing lung surgery. If the test works, it cou…
Sponsor: University Hospital, Rouen • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Breath sniff test could spot COVID and flu in hospital patients
Diagnosis Not yet recruitingThis study tests whether analyzing chemicals in a person's breath can quickly identify serious respiratory infections like COVID-19, flu, and Legionella in hospitalized patients. Researchers will collect breath samples from 777 adults using a simple bag, then analyze them in a la…
Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
New blood test aims to predict which cancer patients will benefit from immunotherapy
Diagnosis Not yet recruitingThis study is developing a blood test called NeutroFlow that measures specific immune cells (neutrophils) to predict whether cancer patients will benefit from immunotherapy. Researchers will collect blood samples from 600 patients with several types of cancer before they start tr…
Sponsor: OncoHost Ltd. • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
Can a common steroid shield breast cancer patients from a dangerous drug side effect?
Prevention Not yet recruitingTrastuzumab deruxtecan (T-DXd) treats metastatic breast cancer but can cause interstitial lung disease (ILD), a form of lung inflammation that sometimes forces patients to stop treatment. Researchers are testing whether giving dexamethasone before each T-DXd infusion lowers the c…
Phase 3 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
An animated video takes aim at missed lung cancer screening
Prevention Not yet recruitingResearchers at Johns Hopkins University are testing whether a short animated video and brochure, sometimes followed by a phone call, can help people at higher risk of lung cancer get low-dose CT screening. The trial enrolls adults aged 50 to 80 with a significant smoking history …
Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
Could a toothbrush and mouthwash cut pneumonia in the elderly?
Prevention Not yet recruitingThis trial tests whether training nursing home staff to provide better oral hygiene can reduce pneumonia in residents aged 60 and older. Participants will use special toothpastes and mouthwashes, including stannous fluoride and chlorhexidine options. The study measures how many r…
Phase 4 • Sponsor: Colgate Palmolive • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
New strategies aim to boost lung cancer screening and save lives
Prevention Not yet recruitingThis study tests a program called Empower LCS/Call+ to help adults who are at high risk for lung cancer complete their recommended screening. The program includes educational materials, reminders for patients and doctors, and support with financial or community resources. Some pa…
Sponsor: University of California, Irvine • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
Can a lower dose of antibiotics prevent pneumonia just as well after kidney transplant?
Prevention Not yet recruitingThis study tests whether a lower dose of the antibiotic TMP-SMX works as well as the standard dose to prevent a serious lung infection called PJP in people who have just had a kidney transplant. About 1,084 adult first-time kidney transplant recipients will take either a low or s…
Phase 4 • Sponsor: Anhui Provincial Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Text messages could boost lung cancer screening in underserved communities
Prevention Not yet recruitingThis study aims to find the best ways to increase lung cancer screening among current and former smokers aged 50-80 in community health centers. About 19,000 participants will receive text messages and clinic support to complete eligibility checks and low-dose CT scans. The goal …
Sponsor: University of Utah • Aim: Prevention
Last updated Jun 27, 2026 12:38 UTC
-
Cold plasma zapped into groin wounds may stop healing woes
Prevention Not yet recruitingThis study tests whether a single dose of cold atmospheric plasma applied to the wound during groin surgery can prevent healing complications in 214 high-risk patients with peripheral artery disease. Half will get the real plasma device, half a sham device. Researchers will track…
Sponsor: Ursula Werra • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
New combo approach aims to stop pneumonia in ventilated patients
Prevention Not yet recruitingThis study tests whether using two automated devices together—one that drains fluids from above the breathing tube and another that monitors the tube's cuff pressure—can reduce the amount of fluid entering the lungs of critically ill patients on ventilators. The goal is to preven…
Sponsor: University Hospital, Lille • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
New trial aims to stop pneumonia in ventilated kids with nebulized antibiotic
Prevention Not yet recruitingThis study tests if giving a nebulized antibiotic (colistimethate sodium) can prevent pneumonia in children who are on breathing machines. About 400 children aged 1 month to 14 years will receive either the drug or a placebo twice daily for up to 7 days. The goal is to see if the…
Phase 2/3 • Sponsor: University Hospital Fattouma Bourguiba • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
Can rain sounds make breathing exercises work better for COPD?
Symptom relief Not yet recruitingResearchers are testing whether pranayama breathing exercises, done to the sound of rain, can ease breathlessness and improve confidence in daily activities for people with COPD. The trial enrolls 114 adults with mild to moderate COPD and assigns them to one of three groups: pran…
Sponsor: Inonu University • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can a handheld breathing device and phone app help COPD patients breathe easier?
Symptom relief Not yet recruitingRESP-FIT tests whether a home-based breathing muscle training program, paired with a mobile app for symptom tracking and activity monitoring, can improve breathlessness, breathing strength, and physical activity in adults with COPD. Researchers are enrolling 288 adults aged 40 an…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can a breathing routine ease COPD breathlessness?
Symptom relief Not yet recruitingResearchers are testing whether a structured breathing program called Active Cycle of Breathing Techniques, combined with a handheld positive expiratory pressure device, can improve breathing, sleep, and mood in people with COPD. The trial enrolls 60 adults aged 40 to 90 with dia…
Sponsor: National Yang Ming Chiao Tung University Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Could less be more? new trial tests lower antibiotic dose for pneumonia
Symptom relief Not yet recruitingThis study compares two doses of the antibiotic ceftriaxone for adults hospitalized with pneumonia (but not in the ICU). The goal is to see if a 1-gram daily dose works just as well as a 2-gram daily dose while causing fewer side effects. About 430 participants will be followed t…
Phase 4 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Breathing exercises put to the test for scarred lungs
Symptom relief Not yet recruitingResearchers compare two breathing techniques added to standard medical care for people with stable pulmonary fibrosis. Forty adults with mild to moderate lung restriction join the study. One group receives a manual diaphragmatic release technique, where a therapist applies gentle…
Sponsor: Pharos University in Alexandria • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a community health worker lighten the load for rural caregivers?
Symptom relief Not yet recruitingThis study tests whether a trained community health worker, who provides remote support, can reduce the burden and improve satisfaction for rural caregivers of older veterans with serious illnesses like dementia or cancer. About 480 care partners will be randomly assigned to rece…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a drug stop muscle loss in lung cancer? new trial aims to find out
Symptom relief Not yet recruitingThis early-stage trial tests whether the drug ponsegromab can help adults with advanced non-small cell lung cancer who are losing muscle mass (cachexia). About 80 participants will receive either ponsegromab or a placebo. The study measures changes in muscle size and physical fun…
Phase 1 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Magnetic pulses to the brain may help lung cancer patients sleep after surgery
Symptom relief Not yet recruitingThis trial tests whether low-frequency repetitive transcranial magnetic stimulation (rTMS) can improve sleep quality in adults undergoing surgery for lung cancer. Participants with poor sleep before surgery will receive either active rTMS or a sham (inactive) treatment over five …
Phase 2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Magnetic pulses to the brain may help cancer patients sleep better
Symptom relief Not yet recruitingThis trial tests whether low-frequency repetitive transcranial magnetic stimulation (rTMS) can improve sleep quality in adults with advanced non-small cell lung cancer who have trouble sleeping during hospital stays. Researchers will randomly assign 160 participants to receive ei…
Phase 2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Virtual reality may help COPD patients breathe easier during exercise
Symptom relief Not yet recruitingThis trial tests whether wearing a virtual reality headset during pulmonary rehabilitation can reduce shortness of breath and improve exercise tolerance in people with chronic respiratory disease like COPD. Participants will do a cycling exercise test twice, once with VR and once…
Sponsor: Fondation Hôpital Saint-Joseph • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Could a WeChat app add minutes to your child's sleep?
Symptom relief Not yet recruitingThis trial tests whether Sleep Island, a WeChat mini-program for parents, can help preschool children sleep longer. Researchers will randomly assign 122 families to either use the app for 4 weeks or receive standard sleep education. The app tracks the child's sleep, gives persona…
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Healing together: could a Couples-Based program ease ICU aftermath?
Symptom relief Not yet recruitingThis study tests a program called ICU-SUCCEED, designed to help survivors of acute respiratory failure and their family caregivers cope and manage recovery together. The program includes one in-person session and four follow-up sessions by phone or video, focusing on communicatio…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Nature escapes in a headset: a new way to calm cancer infusions?
Symptom relief Not yet recruitingThis randomized trial tests whether immersive virtual reality (VR) can reduce anxiety in people with lung cancer during immunotherapy or chemo-immunotherapy infusions. Half of the 60 participants will use a VR headset showing calming nature scenes during four infusion visits, whi…
Sponsor: Dott.Claudio Sini • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
A personalized approach to breathlessness: could a stepped-care program offer relief for lung cancer patients?
Symptom relief Not yet recruitingShortness of breath, or dyspnea, affects most lung cancer patients and often persists despite standard treatments. This pilot study tests a stepped-care behavioral intervention called INSPIRE, which starts with brief coping skills and adds more intensive psychological support onl…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Could a simple saltwater mist make breathing easier for lung patients?
Symptom relief Not yet recruitingThis study looks at whether adding a continuous saltwater mist to warm, humidified air can make thick lung mucus easier to clear. 35 adults hospitalized with lung conditions like COPD or cystic fibrosis will receive both treatments on separate days. Researchers will measure mucus…
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Can a smartphone app heal the hidden wounds of the ICU?
Symptom relief Not yet recruitingThis study tests a mobile mindfulness program called Lift for people who survived a serious illness in the ICU and now struggle with depression, anxiety, or stress. About 450 adults will use either the Lift app or a health education app for 6 months. The goal is to see if the min…
Sponsor: Duke University • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Could a muscle relaxant make newborn intubation safer?
Symptom relief Not yet recruitingThis study tests whether adding a muscle relaxant (rocuronium) to standard painkiller (fentanyl) helps doctors place breathing tubes in newborns on the first try, without causing dangerous drops in oxygen or heart rate. About 102 premature or sick babies in a Brazilian NICU will …
Phase 4 • Sponsor: UEA - Universidade Do Estado Do Amazonas • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New radiation technique aims to shield airways and preserve lung function
Symptom relief Not yet recruitingThis trial compares standard radiation therapy with a new method that specifically avoids damaging small airways in the lungs. The goal is to see if this airway-sparing approach helps patients with stage III non-small cell lung cancer retain better breathing function after treatm…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can a morning light session boost immunotherapy? small trial aims to find out
Symptom relief Not yet recruitingThis pilot study tests whether using bright light therapy for an hour each morning, delivered through an iPad app, is tolerable for people with advanced melanoma or non-small cell lung cancer who are about to start immunotherapy. The idea is that synchronizing the body's internal…
Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can a video rehab program help COPD patients in the countryside?
Symptom relief Not yet recruitingThis study tests whether a 12-week remote group rehabilitation program, done via video calls and a smartphone app, can help COPD patients living in remote areas start and stick with rehab. It compares this approach to standard in-person rehab. The goal is to see if the remote opt…
Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Hypnosis may ease breathing trouble in COPD patients
Symptom relief Not yet recruitingThis study tests whether several sessions of medical hypnosis can improve quality of life for people with COPD who still have severe shortness of breath despite standard treatment. About 154 adults with advanced COPD will be randomly assigned to either five hypnosis sessions or f…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Phone app aims to keep lung cancer patients moving during treatment
Symptom relief Not yet recruitingThis study tests whether a smartphone reminder app can help lung cancer patients stay physically active during radiation therapy. About 32 adults with lung cancer will use the app or standard care, and their daily step counts will be compared. The goal is to see if simple digital…
Sponsor: University Hospital Schleswig-Holstein • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Can zoom workouts help older cancer patients in the countryside?
Symptom relief Not yet recruitingThis study tests whether a 12-week exercise program, delivered via Zoom, is practical and helpful for older adults (65+) with cancer who live in rural areas. Participants will do two supervised exercise sessions per week. The goal is to see if the program improves quality of life…
Sponsor: University of Saskatchewan • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Simple moves after heart surgery may save lungs
Symptom relief Not yet recruitingThis study looks at whether changing body position and doing special breathing exercises can help prevent lung issues like pneumonia after heart surgery. About 124 adults having planned heart surgery will be split into four groups: one getting usual care, one doing only breathing…
Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Remote exercise program aims to boost chemo completion in cancer patients
Symptom relief Not yet recruitingThis study tests whether a home-based exercise program can help people with gastrointestinal or lung cancer handle chemotherapy better. Up to 120 participants will be randomly assigned to either an aerobic and resistance exercise group or a stretching group. All activities are do…
Sponsor: AdventHealth Translational Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Can changing how you breathe ease COPD symptoms?
Symptom relief Not yet recruitingThis study tests whether different breathing patterns (pursed-lip breathing with specific inhale/exhale ratios) can improve breathing in people with stable COPD. About 122 participants aged 40 and older will be assigned to one of three breathing ratios or standard care. Researche…
Sponsor: Scholastica Fina Aryu Puspasari • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Simple breathing exercises may cut hospital time after bypass surgery
Symptom relief Not yet recruitingThis study tests whether adding a special breathing exercise device (IMT Threshold) to standard rehab can help people recover faster after coronary artery bypass graft surgery. The goal is to reduce time in the hospital and prevent serious breathing complications like pneumonia. …
Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New nerve block technique aims to ease pain after lung surgery
Symptom relief Not yet recruitingThis study compares a new, simpler nerve block method to the traditional one for people having lung surgery with a camera (VATS). The goal is to see if the new method works just as well for pain control and helps patients recover faster. About 200 adults will be randomly assigned…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Simple breath change could boost COPD inhaler power
Symptom relief Not yet recruitingThis study looks at whether inhaling a bronchodilator (salbutamol) at a different lung volume helps it work better in people with COPD. 30 participants will inhale the medication either from a low lung volume (as usually done) or from a higher, more relaxed volume. The goal is to…
Sponsor: University of Milan • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New dissolving nails could spare kids a second surgery for broken arms
Symptom relief Not yet recruitingThis study tests whether special dissolving nails can heal children's broken forearm bones as well as standard titanium nails. The dissolving nails go away on their own, so many kids might not need a second operation to remove them. About 60 children who need surgery for a displa…
Sponsor: Children's Fractures Interest Group, Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy aims to speed up breathing tube removal in ICU
Symptom relief Not yet recruitingThis study looks at whether adding a type of stretching called proprioceptive neuromuscular facilitation (PNF) to standard breathing exercises helps patients get off a breathing machine faster. About 93 adults in the ICU who are stable and awake will be split into three groups: o…
Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Poop pills for cancer wasting? new trial hopes gut bugs boost appetite
Symptom relief Not yet recruitingThis study tests whether transplanting healthy gut bacteria (fecal microbiota transplantation) can help advanced cancer patients who are losing weight and appetite—a condition called cachexia. About 66 adults with stomach, colorectal, or lung cancer will receive the treatment. Th…
Phase 2 • Sponsor: Hua Jiang • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Exercise before and during chemotherapy may boost treatment success
Symptom relief Not yet recruitingThis study tests whether a supervised exercise program, started two weeks before chemotherapy and continued for 16 weeks during treatment, can help adults aged 35 to 65 with breast, lung, or colon cancer tolerate chemotherapy better. The goal is to see if participants can receive…
Sponsor: University of Vic - Central University of Catalonia • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Pre-Surgery workouts may boost recovery in lung cancer
Symptom relief Not yet recruitingThis study tests whether a supervised exercise program, done alongside chemotherapy or immunotherapy, can improve fitness and recovery in patients with locally advanced non-small cell lung cancer. 74 participants will be randomly assigned to either exercise training or usual care…
Sponsor: Hôpital du Valais • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Freezing lung lining again? small study tests repeat cryospray safety in COPD
Symptom relief Not yet recruitingThis study tests whether it is safe to repeat a procedure called metered cryospray in people with COPD and chronic bronchitis who have already had it once. Only 10 participants will be enrolled. The main goal is to see if the treatment can be fully delivered and to track any seri…
Sponsor: CSA Medical, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New strategy aims to tame treatment side effects in lung cancer patients
Symptom relief Not yet recruitingThis study tests a special care plan to help Chinese patients with advanced EGFR-mutated lung cancer who are taking the drug amivantamab. The plan focuses on preventing common side effects like blood clots, skin rashes, and infusion reactions. About 122 adults will join to see if…
Phase 4 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Sneakers could be a simple fix for COPD breathing trouble
Symptom relief Not yet recruitingThis study looks at whether special 'active' sports shoes can help people with severe COPD walk farther during a 6-minute walk test. About 75 adults with advanced COPD will try both the special shoes and their usual shoes, and researchers will compare how far they walk and how br…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New breathing device aims to unclog lungs in bronchiectasis patients
Symptom relief Not yet recruitingThis pilot study will test the Simeox 200, a device designed to help clear mucus from the lungs, in 35 adults with bronchiectasis who produce a lot of phlegm. Participants will use the device twice daily for two weeks, and researchers will measure how much mucus is cleared, along…
Sponsor: Inogen Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Two weeks of walking and breathing before lung surgery may cut pain and hospital stay
Symptom relief Not yet recruitingThis study looks at whether a two-week program of walking and breathing exercises before surgery for non-small cell lung cancer can help reduce pain, speed up recovery, shorten hospital stays, and improve quality of life. About 62 adults scheduled for surgery will be split into t…
Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Could skipping the breathing tube make lung surgery recovery easier?
Symptom relief Not yet recruitingThis study compares a newer anesthesia method where patients breathe on their own during lung surgery to the standard method using a breathing tube and machine. About 1,600 people having minimally invasive lung nodule removal will be randomly assigned to one of the two methods. T…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Color-Changing cards could soothe scared kids during breathing treatments
Symptom relief Not yet recruitingThis study will test whether using special distraction cards or color-changing thermochromic cards can reduce pain, fear, and anxiety in children aged 4-6 who are receiving inhaler therapy for respiratory infections. About 90 children will be randomly assigned to use one type of …
Sponsor: Muhammed Ata Nur GEÇER • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Could a digital device help COPD patients breathe easier?
Symptom relief Not yet recruitingThis study tests a digital breathing trainer that helps COPD patients strengthen their breathing muscles through forceful inhales and exhales. Sixty participants with moderate to severe COPD will use the device twice daily for eight weeks, alongside standard rehab. Researchers wi…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Zapping the brain to clear the fog of COPD?
Symptom relief Not yet recruitingThis study tests if a gentle, non-invasive brain stimulation method can improve memory and attention in people with COPD who have thinking problems. Twenty-four adults with stable COPD and mild cognitive issues will receive either real or fake stimulation for 20 minutes a day, 5 …
Sponsor: Shahad Abdulrahman Alkandari • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Hypnosis audio may sharpen lung cancer scans
Symptom relief Not yet recruitingThis study tests whether listening to a hypnotic audio recording during a 4D CT scan can reduce image artifacts (blurring or distortions) for 25 adults receiving lung cancer radiation therapy. Participants will have scans with and without the recording to compare quality. The goa…
Sponsor: Centre Leon Berard • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Could you help scientists unlock genetic cancer secrets?
Knowledge-focused Not yet recruitingThis study screens up to 1,000 people with personal or family histories of certain cancers to see if they qualify for ongoing genetics research at the National Cancer Institute. Participants fill out a 15-20 minute online survey about their health and family history. No treatment…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Why do some preterm babies need breathing machines longer?
Knowledge-focused Not yet recruitingResearchers at Assiut University Children Hospital are tracking 100 preterm infants who need invasive mechanical ventilation in the neonatal intensive care unit. The study aims to identify which early factors predict prolonged ventilation, defined as more than 7 days or frequent …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Finger-Prick blood tests could let lung cancer patients skip clinic visits
Knowledge-focused Not yet recruitingResearchers are testing whether people with non-small cell lung cancer can collect their own small blood samples at home using a finger-prick kit. Participants receive standard treatment with docetaxel, paclitaxel, alectinib, or lorlatinib, and the samples measure how much cancer…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Is thicker blood a hidden player in ARDS?
Knowledge-focused Not yet recruitingARDS is a severe lung condition that damages the tiny air sacs and blood vessels in the lungs, leading to low oxygen and unstable circulation. Researchers at Hospices Civils de Lyon are measuring blood viscosity, or how thick and resistant to flow the blood is, in ICU patients wi…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
AI could slash MRI scan times without sacrificing quality
Knowledge-focused Not yet recruitingThis study explores whether artificial intelligence can help perform high-field whole-body MRI scans faster while keeping image quality high. Researchers will compare standard MRI sequences with AI-accelerated versions in 600 adults undergoing screening for prostate, lung, or vas…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
The breathing muscle that may hit pause: scientists probe diaphragm hibernation in ICU
Knowledge-focused Not yet recruitingResearchers at Radboud University Medical Center are studying whether the diaphragm, the main breathing muscle, enters a hibernation-like state in ICU patients who need a breathing machine. The study follows 112 adults on invasive mechanical ventilation for at least three days. S…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Can a bedside ultrasound predict which septic shock patients will stop breathing on their own?
Knowledge-focused Not yet recruitingResearchers are studying whether repeated bedside ultrasound scans of the diaphragm can predict breathing failure in adults with septic shock. The study follows 120 patients in intensive care for up to 72 hours, measuring how far the diaphragm moves and how thick it is. The team …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Leftover immunotherapy may boost chemo: new study investigates timing
Knowledge-focused Not yet recruitingThis study looks at how much pembrolizumab (an immunotherapy drug) remains in the blood after treatment ends and whether that affects how well chemotherapy works later. Researchers will follow 110 people with non-small cell lung cancer or head and neck cancer who have stopped pem…
Phase 4 • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Your gut bacteria may hold the key to whether immunotherapy works
Knowledge-focused Not yet recruitingResearchers are studying whether the mix of bacteria in a person's gut can predict how well they respond to immunotherapy drugs called immune checkpoint inhibitors. The trial enrolls about 360 adults with advanced non-small cell lung cancer, melanoma, endometrial cancer, or cervi…
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Brazil tests lung cancer screening in smokers
Knowledge-focused Not yet recruitingThis study will screen 477 current or former smokers in Brazil for lung cancer using CT scans. It aims to see how often the scans give false alarms (false positives) in a region where lung infections are common. The goal is to improve screening accuracy and reduce unnecessary fol…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Tiny babies, big challenge: new pain scale for preemies born before 27 weeks
Knowledge-focused Not yet recruitingThis study aims to develop a new pain assessment scale, called EDEX, specifically for extremely premature infants born before 27 weeks. Current scales may not work well for these fragile babies, who show pain in subtle ways. Researchers will create the scale and then test it agai…
Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Freezing probe aims to kill lung tumors through the airways
Knowledge-focused Not yet recruitingResearchers are testing an experimental cryoablation catheter that freezes lung tissue, using donated human lungs kept alive outside the body. The goal is to see whether the device can reach and cool tumors through the airways, which could offer a less invasive option than surger…
Sponsor: Endocision Technologies Inc. • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Why does lung surgery leave some patients breathless? glasgow team probes the right heart
Knowledge-focused Not yet recruitingSome people who have keyhole lung cancer surgery develop lasting breathlessness and struggle with gentle exercise, even if their breathing was fine before. Researchers suspect the right side of the heart, which pumps blood to the lungs, may be weakened by the extra pressure it fa…
Sponsor: University of Glasgow • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Sugar tracer reveals how immune cells fuel up in the ICU
Knowledge-focused Not yet recruitingResearchers at Vanderbilt University Medical Center want to understand how immune cells use glucose, the body's main sugar, during critical illness. They give 25 adult ICU patients an intravenous infusion of a non-radioactive carbon-13 glucose tracer over a few hours. Then they c…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
New study aims to understand physical challenges in kids with nerve diseases
Knowledge-focused Not yet recruitingThis study will look at balance, core strength, leg strength, walking ability, and fatigue in 32 children aged 6-18 with demyelinating diseases (conditions affecting the protective coating of nerves). Each child will undergo a single session of non-invasive tests like balance exe…
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can a chest infection leave lasting effects on daily life?
Knowledge-focused Not yet recruitingThis study follows adults hospitalized with a lower respiratory tract infection, such as pneumonia or bronchitis, to measure how their quality of life changes over one year. Researchers use a standard questionnaire to track physical, mental, and social well-being at several point…
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can a week at sea level ease the strain of High-Altitude heart disease?
Knowledge-focused Not yet recruitingResearchers are testing whether a one-week stay at sea level improves walking ability and blood oxygen in people with pulmonary arterial hypertension who live permanently above 2600 meters. The study compares these patients with healthy controls from the same altitude, measuring …
Sponsor: Silvia Ulrich Somaini • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Can a week at sea level ease the strain of High-Altitude lung disease?
Knowledge-focused Not yet recruitingThis study looks at whether a one-week stay at sea level helps people with pulmonary arterial hypertension (PAH) who live permanently above 2600 meters. Researchers will measure lung function, blood oxygen, and sleep quality before, during, and after the descent and re-ascent. Th…
Sponsor: Silvia Ulrich Somaini • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
AI could help detect lung cancer earlier in High-Risk smokers
Knowledge-focused Not yet recruitingThis study will enroll 1,500 current or former smokers aged 50-80 to see if an artificial intelligence (AI) model can help doctors better detect lung nodules and predict cancer spread. Participants will undergo CT scans, and the AI's results will be compared to standard radiologi…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
A global effort to make moving critically ill patients safer
Knowledge-focused Not yet recruitingThis international study follows about 565 patients who need advanced breathing support, such as high-flow oxygen or a ventilator, while being transported within or between hospitals. Researchers will track what happens during these trips, including any equipment problems or inte…
Sponsor: Medipol University • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Can a week at sea level ease strain on the Heart's blood vessels?
Knowledge-focused Not yet recruitingThis trial asks whether a one-week stay at sea level can lower blood pressure in the lungs of people with pulmonary arterial hypertension who live permanently above 2600 meters. Researchers will compare heart and lung measurements taken at high altitude with those taken after sev…
Sponsor: Silvia Ulrich Somaini • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Can a week at sea level ease the strain of High-Altitude living on the heart?
Knowledge-focused Not yet recruitingThis study looks at what happens when people with pulmonary arterial hypertension, a condition that raises pressure in the lung's blood vessels, travel from their homes above 2600 meters down to sea level for a week, and then return. Researchers will measure heart rate variabilit…
Sponsor: Silvia Ulrich Somaini • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can a week at sea level ease sleep and oxygen strain for High-Altitude heart patients?
Knowledge-focused Not yet recruitingResearchers are studying what happens when people with pulmonary arterial hypertension who live above 2600 meters spend a week at sea level. The trial compares their sleep, blood oxygen, and breathing during sleep at altitude and after seven days at sea level. It includes both pa…
Sponsor: Silvia Ulrich Somaini • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can a new inhaled COPD drug deliver the same effect with less body exposure?
Knowledge-focused Not yet recruitingResearchers are testing whether a new inhaled version of glycopyrrolate, called AERO-002, delivers the drug to the lungs with less of it entering the bloodstream compared to a standard inhaled glycopyrrolate product. The study enrolls healthy adults aged 18 to 55 who will receive…
Phase 1 • Sponsor: AeroRx Therapeutics Inc. • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can a COPD flare-up starve your muscles of oxygen?
Knowledge-focused Not yet recruitingResearchers at Hacettepe University are comparing muscle oxygen levels in people hospitalized with a COPD flare-up versus those with stable COPD. They use a light-based sensor to measure oxygen in breathing and limb muscles during simple tasks like standing up and walking. The go…
Sponsor: Hacettepe University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Could the air in your living room worsen COPD? a trial puts home sensors to the test
Knowledge-focused Not yet recruitingThis pilot study follows 15 adults with COPD who recently left the hospital after a flare-up. Researchers place sensors in their homes to measure air quality, light, noise, and temperature, while participants wear a smartwatch that tracks health data. For one month, participants …
Sponsor: Ziekenhuis Oost-Limburg • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
A deep dive into tumor markers could personalize lung cancer care
Knowledge-focused Not yet recruitingResearchers are collecting blood and tumor tissue samples from 30 adults with relapsed small-cell lung cancer who are receiving a standard DLL3 T cell engager therapy. The goal is to track changes in tumor markers over time and see if those changes relate to how well the treatmen…
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Breathing in a special gas: a new MRI lens on lung fibrosis treatment
Knowledge-focused Not yet recruitingThis observational study explores whether a specialized MRI technique using inhaled hyperpolarized xenon gas can detect how approved antifibrotic therapies affect the lungs of adults with fibrotic interstitial lung disease. Researchers will compare imaging changes with standard t…
Sponsor: Dr. Grace Parraga • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Lung cancer study seeks to map patient journeys
Knowledge-focused Not yet recruitingThis study reviews medical records of 250 people with advanced or metastatic non-small cell lung cancer that has a specific change in the EGFR gene. Researchers want to learn about patients' backgrounds, the treatments they receive, and how well those treatments work. The goal is…
Sponsor: Janssen-Cilag Farmaceutica Ltda. • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Could a lung tissue bank unlock new treatments for COPD and asthma?
Knowledge-focused Not yet recruitingThis study aims to create a large collection of lung and airway tissue samples from people with COPD, asthma, and healthy volunteers. Researchers will gather samples through bronchoscopy, sputum, nasal brushing, and blood draws during routine procedures or surgeries. The goal is …
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
New study aims to improve inhaler treatment for lung fungus
Knowledge-focused Not yet recruitingThis study looks at how well an inhaled antifungal drug (liposomal amphotericin B) reaches the lungs in people with chronic pulmonary aspergillosis, a long-term lung infection. About 18 adults will inhale two different doses on separate days and then have special scans to see whe…
Phase 1 • Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Can Home-Based lung rehab win over more COPD patients?
Knowledge-focused Not yet recruitingThis study looks at why some adults with chronic obstructive pulmonary disease (COPD) accept or decline a home-based pulmonary telerehabilitation program. By comparing the characteristics of those who agreed to participate with those who did not, researchers hope to identify barr…
Sponsor: ADIR Association • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Can a gentle nasal breeze unclog the Lungs' smallest airways?
Knowledge-focused Not yet recruitingThis study looks at how nasal high-flow therapy—a device that delivers warm, moist air through small nasal tubes—affects the airways of people with severe chronic obstructive pulmonary disease (COPD). Researchers will measure airway resistance and other lung mechanics using a non…
Sponsor: ADIR Association • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Could a spirometer test guide breathing support in respiratory failure?
Knowledge-focused Not yet recruitingThis study looks at whether the amount of air a person breathes in on their own matches the amount they breathe when using a non-invasive ventilation (NIV) mask. It involves 30 adults with acute respiratory failure who are in intensive care. Researchers will measure tidal volume …
Sponsor: Centre Hospitalier Departemental Vendee • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Can a 30-hour e-learning course equip family doctors to deliver better palliative care?
Knowledge-focused Not yet recruitingThis trial explores whether a training program for general practitioners can improve how primary care clinics deliver palliative care to adults with advanced cancer, COPD, heart failure, or kidney disease. One family health unit will use the new approach—a 30-hour e-learning cour…
Sponsor: University of Coimbra • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Which ventilator setting saves more lungs? a Head-to-Head test
Knowledge-focused Not yet recruitingThis study compares different bedside methods for choosing the optimal ventilator pressure (PEEP) in patients with moderate-to-severe acute respiratory distress syndrome (ARDS). The goal is to see if these methods give similar results and which one best balances keeping lungs ope…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Can immune profiling unlock the hidden stages of tuberculosis?
Knowledge-focused Not yet recruitingThis study aims to better understand tuberculosis (TB) across its entire spectrum—from early, symptom-free infection to active disease and after treatment. Researchers will recruit TB patients and their close contacts to analyze immune responses and identify biomarkers that could…
Sponsor: Irene Latorre Rueda • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Ventilator may harm the brain, not just the lungs – study eyes link
Knowledge-focused Not yet recruitingThis study looks at whether the force of mechanical ventilation in patients with acute respiratory distress syndrome (ARDS) can damage the brain. Researchers will measure a protein called S100B in the blood, which is a sign of brain injury, and track thinking and memory problems …
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
What makes someone stop a lung fibrosis drug? a study asks patients directly
Knowledge-focused Not yet recruitingThis study uses web-based interviews to explore how adults in Japan with pulmonary fibrosis decide whether to continue or stop antifibrotic therapy after experiencing side effects. Researchers aim to understand the personal and psychological factors behind these decisions. The fi…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
A smarter way to track lung disease? new platform aims to personalize COPD and IPF care
Knowledge-focused Not yet recruitingThis study is testing whether an integrated precision medicine platform can improve how doctors diagnose and manage chronic inflammatory lung diseases like COPD and idiopathic pulmonary fibrosis. Researchers will collect blood and saliva samples for biomarker analysis, monitor in…
Sponsor: Fondazione Don Carlo Gnocchi ETS • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can an inhaled powder stop lung scarring? a safety trial begins
Knowledge-focused Not yet recruitingThis phase 1 trial tests whether an inhaled experimental drug called ICF004 is safe and how the body processes it. Healthy Chinese adults aged 18 to 50 will breathe in either a single or multiple doses of ICF004 or a placebo via a dry powder inhaler. The study aims to identify an…
Phase 1 • Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Listening to the unheard: how patients navigate cancer of unknown primary
Knowledge-focused Not yet recruitingThis study explores the personal stories of people diagnosed with cancer of unknown primary (CUP) and their carers. Through interviews and focus groups, researchers aim to understand the emotional and practical challenges of living with this uncertain diagnosis. The findings will…
Sponsor: The Clatterbridge Cancer Centre NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
New study aims to Fine-Tune ventilator strategies for ARDS patients
Knowledge-focused Not yet recruitingThis study looks at two bedside methods to measure how much of the lung can be reopened in patients with acute respiratory distress syndrome (ARDS) who are on a ventilator. It also compares four different ways to set the ventilator's positive end-expiratory pressure (PEEP). The g…
Sponsor: Oriol Roca • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Does the setting of care affect whether kids finish their antibiotics?
Knowledge-focused Not yet recruitingThis observational study looks at whether children aged 3 months to 16 years are more likely to complete their full course of antibiotics when prescribed at a primary care clinic versus a hospital emergency department. Researchers surveyed parents by phone after treatment ended t…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Glowing drug reveals why lung cancer immunotherapy fails
Knowledge-focused Not yet recruitingThis study tests a new way to see where an immunotherapy drug goes in the lungs of people with stage III lung cancer. Twenty participants will receive a small dose of a fluorescent version of the drug durvalumab, then have a special camera bronchoscopy to spot the drug in tumors …
Phase 2 • Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Smart sensors aim to predict dangerous COPD attacks before they happen
Knowledge-focused Not yet recruitingThis study follows 250 adults with severe COPD who use a breathing machine at home. Researchers collect data from sensors and regular check-ups to build a model that can warn of an upcoming flare-up. The goal is to catch problems early and reduce hospital visits.
Sponsor: Beijing Chao Yang Hospital • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Blood cancer patients may need higher antibiotic doses to beat superbugs
Knowledge-focused Not yet recruitingThis study looks at whether the standard dose of the antibiotic ceftazidime-avibactam reaches high enough levels in the blood of people with blood cancers or those who have had a stem cell transplant. These patients are at high risk for severe infections from drug-resistant bacte…
Sponsor: Sizhou Feng • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Can a quick ultrasound help doctors decide faster on antibiotics for pneumonia?
Knowledge-focused Not yet recruitingThis pilot study tests whether using pleuropulmonary ultrasound in the emergency department can help doctors prescribe antibiotics sooner for suspected pneumonia. Fifteen adults with respiratory symptoms will receive an ultrasound in addition to standard care. The main goal is to…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Lab-Grown lung tumors could reveal why some drugs work and others fail
Knowledge-focused Not yet recruitingThis study takes leftover tumor samples from people with EGFR-mutant non-small cell lung cancer and grows them in the lab as cell cultures and organoids. Researchers will test different anti-EGFR drugs on these models to see which ones work best for each type of mutation and expl…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Tiny bacterial particles linked to lung damage in sepsis patients
Knowledge-focused Not yet recruitingThis study investigates whether a particularly dangerous strain of Klebsiella pneumoniae bacteria (hvKP) raises the risk of lung injury in adults with sepsis, compared to a more common strain. Researchers will analyze blood samples for tiny bacterial particles and markers of a sp…
Sponsor: Southeast University, China • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Blood test may reveal hidden cancer spread without scans
Knowledge-focused Not yet recruitingThis study is testing whether a blood test can locate where colorectal cancer has returned or spread after surgery. Researchers are analyzing genetic markers in the blood to build a model that predicts whether a recurrence is local or distant. The goal is to improve early detecti…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Pneumonia culprit may be rarer than doctors think
Knowledge-focused Not yet recruitingThis study looks at 200 people with pneumonia to find out how many actually have an infection caused by Chlamydia pneumoniae, a type of bacteria. Researchers will use PCR tests to check for the germ and compare results with standard care. The goal is to see if this infection is o…
Sponsor: Centre Hospitalier de Saint-Denis • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Can targeted sedation help patients breathe easier on oxygen therapy?
Knowledge-focused Not yet recruitingThis study looks at how two sedative drugs, dexmedetomidine and remifentanil, affect breathing effort in patients with acute hypoxemic respiratory failure who are receiving high-flow nasal oxygen. Researchers will measure changes in inspiratory effort and symptoms like shortness …
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Virtual reality reveals how Kids' hearing develops in chaotic soundscapes
Knowledge-focused Not yet recruitingThis study measures how children ages 7 to 15 with normal hearing understand speech in realistic noisy environments, like a school cafeteria or playground. Using a 360-degree sound system, researchers play sentences in different background noises to see how well kids repeat them.…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Scientists build a biobank to decode ARDS and personalize treatment
Knowledge-focused Not yet recruitingThis study collects blood samples and health data from 1,200 adults with ARDS in intensive care. Researchers aim to identify biological markers that can group patients into subtypes and predict how they will respond to different treatments. The goal is to improve care for this li…
Sponsor: Prenosis, Inc. • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Tight bands on legs may boost workout benefits for lung disease patients
Knowledge-focused Not yet recruitingThis study tests whether using a blood flow restriction (BFR) device during exercise can increase muscle fatigue in people with COPD, potentially making rehab more effective. Forty participants will do one session of resistance or cycling exercise with and without BFR. The goal i…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Home devices may spot lung flare-ups before they become emergencies
Knowledge-focused Not yet recruitingThis study tests whether people with fibrotic interstitial lung disease can use home monitoring devices—like a spirometer, pulse oximeter, and scale—to help detect serious lung events such as flare-ups or hospitalizations. About 200 participants will use these devices connected t…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Blood test could reveal how lung cancer evolves during treatment
Knowledge-focused Not yet recruitingThis study uses blood tests (liquid biopsies) to track how small cell lung cancer changes during chemotherapy and immunotherapy. Researchers will analyze DNA from blood samples taken before, during, and after treatment in 50 patients. The goal is to understand why some cancers be…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
ARDS ventilator tool faces reliability test
Knowledge-focused Not yet recruitingThis study looks at whether the recruitment-to-inflation ratio (R/I ratio), a measurement used to guide ventilator settings in patients with acute respiratory distress syndrome (ARDS), gives the same result when repeated in the same patient. Researchers will measure it twice in 8…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Which breathing test is safer for ICU patients? new study aims to find out
Knowledge-focused Not yet recruitingThis study looks at 88 ICU patients who are ready to try breathing on their own after being on a ventilator. Some patients will be taken off the ventilator completely (T-piece test), while others will breathe with a little machine help (PS-ZEEP test). The goal is to see which tes…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Body clock check: a simple swab may guide immunotherapy timing for lung cancer
Knowledge-focused Not yet recruitingThis study explores whether a hair follicle or cheek swab can accurately measure a person's internal body clock (circadian rhythm) in patients with advanced lung cancer receiving immunotherapy. Researchers will use a new tool called TimeTeller to analyze gene activity from these …
Sponsor: Laura Longshaw • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Scientists track hidden threat of antibiotic resistance in lung patients
Knowledge-focused Not yet recruitingThis study follows people with chronic lung diseases like bronchiectasis, cystic fibrosis, and COPD to understand how bacteria become resistant to antibiotics. Researchers will collect samples and health data over time to map resistance patterns and genetic causes. The goal is to…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New study aims to predict survival in respiratory care units
Knowledge-focused Not yet recruitingThis study will collect data from 624 patients in respiratory intermediate care units (RICUs) across Catalonia to build a model that predicts 30-day survival. Researchers will also test an artificial intelligence approach and create a quick app for doctors. The goal is to better …
Sponsor: Hospital Universitari de Bellvitge • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Massive study to uncover how air pollution triggers lung cancer in india
Knowledge-focused Not yet recruitingThis study will enroll over 3,200 adults in Delhi and surrounding areas to understand how air pollution, especially fine particles (PM2.5), combines with other factors like smoking and genetics to increase lung cancer risk. Researchers will also look for biomarkers and identify g…
Sponsor: All India Institute of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
AI reads CT scans to predict which lung nodules turn cancerous
Knowledge-focused Not yet recruitingThis study will develop an artificial intelligence model that uses a patient's series of CT scans over time to predict whether a lung nodule will grow or become cancerous. Researchers will analyze scans from nearly 5,000 people to train the AI to recognize different growth patter…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Timing is everything: new study seeks best sequence for brain metastases treatment
Knowledge-focused Not yet recruitingThis observational study looks at adults with non-small cell lung cancer that has spread to the brain. Researchers want to see if getting radiation and immunotherapy 30 days apart or closer together changes how long the brain tumors stay stable and how long patients live. Partici…
Sponsor: Xiangya Hospital of Central South University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
New study aims to simplify oxygen weaning for breathing patients
Knowledge-focused Not yet recruitingThis study looks at whether a standard step-by-step plan can help adults on high-flow oxygen therapy stop it more quickly and safely. About 2,000 patients across 8 hospitals will be involved. The goal is to see if the plan leads to more patients successfully coming off oxygen wit…
Sponsor: Rush University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Silent danger: ICU patients may choke without knowing it
Knowledge-focused Not yet recruitingThis study looks at how often ICU patients silently inhale food or liquid into their lungs after a breathing tube is removed, without showing obvious signs like coughing. Researchers will compare a routine bedside swallowing test with a more detailed camera test to see if the bed…
Sponsor: Cleveland Clinic Abu Dhabi • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
How strong should you be? new study aims to find out
Knowledge-focused Not yet recruitingThis study will measure leg and handgrip strength in about 2,800 healthy adults and people with chronic lung diseases across Spain, Portugal, and Italy. Researchers want to create normal muscle strength values for these populations and see if the same standards can apply to peopl…
Sponsor: University of Alcala • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New lung monitoring technique aims to reduce surgery complications
Knowledge-focused Not yet recruitingThis study tests whether using a special ventilator monitor to track lung volume during one-lung surgery, combined with lung-opening maneuvers, can prevent lung collapse after surgery. 44 adults having lung surgery will be randomly assigned to either standard care or the monitori…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Face-Down recovery after heart surgery: a simple position change that could save lives?
Knowledge-focused Not yet recruitingThis study looks at whether placing patients face-down (prone) soon after heart surgery can improve how well the right side of the heart works. The idea is that this position helps open up collapsed parts of the lungs, making it easier for the heart to pump blood. About 80 adults…
Sponsor: Sahlgrenska University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
How safe is bronchoscopy for ILD patients? new study aims to find out
Knowledge-focused Not yet recruitingThis study will track 427 adults with interstitial lung disease (ILD) who need a bronchoscopy as part of their care. Researchers want to see how often complications happen within 30 days after the procedure. The goal is to better understand the risks so doctors can make safer cho…
Sponsor: University of Milan • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New study aims to unlock genetic secrets of lung cancer spread
Knowledge-focused Not yet recruitingThis study looks at a specific type of lung cancer called lung adenocarcinoma and how it can spread through tiny air spaces in the lungs. Researchers will collect tumor and healthy tissue samples from 140 patients to find genetic markers that might predict this spread. The goal i…
Sponsor: Universidade Nova de Lisboa • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Can more screening catch lung cancer sooner? big study aims to find out
Knowledge-focused Not yet recruitingThis study looks at medical records of 3,000 adults with lung cancer to see if the stage at diagnosis is shifting to earlier, more curable stages. Researchers will track how often cancer is found through screening programs, chest X-rays, or heart scans. No new treatments or tests…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Can a simple ventilator setting during surgery prevent breathing problems?
Knowledge-focused Not yet recruitingThis study will test whether using higher or standard pressure on a ventilator during surgery helps patients breathe better after waking up. About 360 adults having planned non-chest, non-heart surgery will be randomly assigned to one of two pressure levels. The main goal is to s…
Sponsor: Moscow Multidisciplinary Clinical Center "Kommunarka" • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Gene mutation linked to unexplained emphysema?
Knowledge-focused Not yet recruitingThis study aims to find out how often people with FLNA gene mutations develop emphysema, a type of lung disease. Researchers will use chest CT scans, blood tests, and lung function tests in 70 participants. The goal is to confirm if FLNA changes are a cause of unexplained emphyse…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New Real-Time imaging could make radiation therapy more precise
Knowledge-focused Not yet recruitingThis study tests whether a new real-time imaging method can make radiation therapy more accurate for cancer patients. About 40 adults with various cancers will receive their normal radiation treatment while the new imaging tracks the tumor in real time. The goal is to see if the …
Sponsor: University of Sydney • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Leg artery check may spot hidden lung cancer risk
Knowledge-focused Not yet recruitingThis study looks at whether people with peripheral vascular disease (narrowed leg arteries) might also be at high risk for lung cancer because of shared smoking history. Researchers will check if these patients qualify for lung cancer screening and refer them for a low-dose CT sc…
Sponsor: International Agency for Research on Cancer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Pharmacies get High-Tech help to fight lung disease
Knowledge-focused Not yet recruitingThis study tests a new computer system that helps pharmacists provide better care for people with COPD, a serious lung disease. The system guides pharmacists to check symptoms, adjust medications, and create action plans. About 25 pharmacy staff and their COPD patients will use t…
Sponsor: Women's College Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Surgeons try High-Tech goggles to map cancer before cutting
Knowledge-focused Not yet recruitingThis study tests whether a special headset (extended reality) can help surgeons plan the removal of cancer-affected lymph nodes in the neck for people with lung cancer. Ten patients will have their PET and CT scans combined into a 3D model that the surgeon views just before surge…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Massive DNA hunt aims to predict who gets critically ill
Knowledge-focused Not yet recruitingThis observational study will collect blood samples from 25,000 adult ICU patients in Sweden to look for genetic variants linked to severe illness from infections, sepsis, or organ failure. Participants also give samples 3-6 months after leaving the hospital. The goal is to build…
Sponsor: Uppsala University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Could you have undiagnosed COPD? new study aims to find out
Knowledge-focused Not yet recruitingThis study will screen 200 adults during a lung health campaign to find undiagnosed breathing problems like COPD. Participants will take a simple breathing test. The goal is to learn how many people have hidden lung issues and how this affects their medical care.
Sponsor: Centre Hospitalier de la côte Basque • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New ICU strategy aims to close deadly gap for hispanic patients with respiratory failure
Knowledge-focused Not yet recruitingHispanic patients are twice as likely to die from respiratory failure as non-Hispanic patients, partly due to deeper sedation and less physical therapy. This pilot study will test a 'safer sedation bundle'—a set of tools and practices to help ICU staff follow guidelines more clos…
Sponsor: New York University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Could a simple sedation plan transform recovery for ECMO patients?
Knowledge-focused Not yet recruitingThis study looks at whether a new, carefully designed plan for giving painkillers and sedatives to patients on ECMO (a life-support machine) is possible to use in hospitals. ECMO patients often face long-term problems like anxiety and memory issues, which may be linked to how muc…
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
ER study to determine best breathing aid for oxygen crisis
Knowledge-focused Not yet recruitingThis study will compare two non-invasive breathing support methods—a face mask that pushes air in and a special nasal tube that delivers high-flow oxygen—for adults in the emergency room with dangerously low blood oxygen. About 500 participants will be randomly assigned to one me…
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Could your Surgeon's tool choice stop that nagging cough?
Knowledge-focused Not yet recruitingThis study looks at how different surgical tools used during lung cancer surgery might affect coughing after the operation. About 248 adults having right lung surgery will be randomly assigned to one of two tool types. The goal is to find out which tool causes less nerve damage a…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Apple goggles guide lung surgeons: safer cuts ahead?
Knowledge-focused Not yet recruitingThis study tests whether the Apple Vision Pro headset can help surgeons see blood vessels more clearly during lung surgery. Twenty adults scheduled for lung surgery will have a CT scan before the operation, and the surgeon will wear the headset to view 3D images during the proced…
Sponsor: The Second People's Hospital of Huai'an • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Virtual reality sheds light on breathlessness in COPD
Knowledge-focused Not yet recruitingThis study compares how COPD patients and healthy individuals experience breathlessness at rest, during exercise, and in virtual reality. Researchers will also test whether a placebo (high-flow nasal cannula) can change how breathlessness feels. The goal is to better understand t…
Sponsor: University of Deusto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Cancer Patients' samples to fuel Tomorrow's discoveries
Knowledge-focused Not yet recruitingThis study collects blood and tissue samples from 110 adults with advanced lung, head and neck, or mesothelioma cancer. The samples are stored in a biobank to help scientists study cancer genes and find better ways to predict treatment outcomes. Participants do not receive any ex…
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists hunt for genetic tricks behind superbug's antibiotic shield
Knowledge-focused Not yet recruitingThis study aims to find out how often multi-drug resistant Klebsiella pneumoniae bacteria carry genes that help them form biofilms (sticky layers) and pump out antibiotics. Researchers will collect urine, pus, and sputum samples from 100 hospital patients with these infections. T…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study aims to stop unnecessary antibiotics in kids with severe lung infections
Knowledge-focused Not yet recruitingThis observational study will enroll 50 children in intensive care with suspected pneumonia. Researchers will use a new technology called metagenomics to detect all bugs in the lung, and also measure how the body's cells and proteins respond. The goal is to see if this combined a…
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study aims to uncover hidden viral threats in seniors
Knowledge-focused Not yet recruitingThis study will look at 5,900 hospitalized adults aged 60 and older to find out which viruses cause severe lung infections. Researchers will test respiratory samples to track common and emerging viruses like flu, RSV, and COVID-19. The goal is to better understand how often these…
Sponsor: Gérond'if • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Wildfire smoke study aims to uncover hidden lung risks
Knowledge-focused Not yet recruitingThis study will expose 24 healthy adults to different levels of wildfire smoke in a safe, controlled room to see how it affects their lungs and brain. Researchers want to understand why some people may be more vulnerable to long-term lung diseases like asthma, COPD, and lung canc…
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Lung cancer study aims to uncover why tumors progress and relapse
Knowledge-focused Not yet recruitingThis study will collect tumor samples and medical data from 150 adults with non-small cell lung cancer (stages I to IV) at Bordeaux University Hospital. Researchers will analyze the molecular, metabolic, and immune features of the tumors to understand how the cancer progresses an…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Simple bike test could revolutionize lung cancer risk assessment
Knowledge-focused Not yet recruitingThis study will test if a simple, low-intensity cycling exercise combined with a handheld monitor can predict serious complications in lung cancer patients before surgery or other treatments. Researchers will include 500 adults with suspected lung cancer. The goal is to make risk…
Sponsor: Linkoeping University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Researchers dig into records to see how breathing help is picked for COPD Flare-Ups
Knowledge-focused Not yet recruitingThis study looks back at the hospital records of 1,000 patients with a sudden worsening of COPD (called an acute exacerbation). The goal is to see how doctors choose and change breathing support—like oxygen masks, high-flow nasal cannulas, or ventilators—during a hospital stay. N…
Sponsor: Sir Run Run Shaw Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Breathe easy: new study tests air quality alerts for safer outdoor exercise
Knowledge-focused Not yet recruitingThis study tests whether giving people with heart or lung conditions real-time air pollution data helps them exercise outdoors more safely. 80 participants will use a smartphone platform that tracks their walking and local air quality. The goal is to see if this approach reduces …
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
New study to track RSV Shot's Real-World power in hospitalized infants
Knowledge-focused Not yet recruitingThis study will look back at medical records of 1,000 babies under 1 year old who were hospitalized with bronchiolitis. Researchers want to see if a new medicine called nirsevimab helped prevent severe RSV infections. The goal is to understand how well the shot works in real life…
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Can texting help veterans with COPD embrace virtual care?
Knowledge-focused Not yet recruitingThis study will test a text-message program called VC-OPTIONS to help Veterans with COPD learn about and use virtual care services like patient portals and telehealth. About 40 Veterans will receive texts from VA's Annie program to see if this approach is easy to use and helpful.…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Hidden hunger in hospitals: new study to reveal malnutrition rates
Knowledge-focused Not yet recruitingThis study aims to find out how many hospitalized patients in Iraq are malnourished, a problem that can lead to more complications and longer stays. Researchers will screen 300 adults in two hospitals using standard tools to identify those at risk. The goal is to gather data to i…
Sponsor: AlFayhaa General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Pilot study to test best ventilator approach for severe lung failure
Knowledge-focused Not yet recruitingThis pilot study will enroll 80 ICU patients with acute hypoxemic respiratory failure to compare two ventilator strategies: one that allows patients to breathe spontaneously and one that fully controls their breathing. The goal is to see if a larger trial is possible and to gathe…
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Could a quick extra flush prevent lung cancer staging errors?
Knowledge-focused Not yet recruitingThis study looks at whether an extra cleaning step during a common lung cancer staging procedure (EBUS) can reduce contamination of tissue samples. Researchers will collect samples from 204 adults with suspected lung cancer. The goal is to see if better cleaning leads to more acc…
Sponsor: University of Mississippi Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New study to reveal hidden impact of ventilator settings on veins
Knowledge-focused Not yet recruitingThis study looks at how different levels of breathing support (PEEP) affect blood flow congestion in the veins of patients with acute respiratory distress syndrome (ARDS). Researchers will use ultrasound to grade congestion in the liver, kidney, and portal veins as absent, modera…
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Shorter lung ultrasound may be just as good in ICU
Knowledge-focused Not yet recruitingThis study will compare a new, shorter lung ultrasound method (using 6 checkpoints) to the standard longer method (12 checkpoints) in 20 ICU patients with acute respiratory failure. The goal is to see if the quicker method gives the same information about lung function and patien…
Sponsor: Clinical Hospital Center Rijeka • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Jaw tracking could spare ICU patients from invasive breathing tests
Knowledge-focused Not yet recruitingThis study tests whether measuring jaw movements can accurately assess breathing effort in intensive care patients with acute respiratory failure. Researchers will compare jaw movement signals to the standard invasive method (esophageal pressure) in 50 adults during weaning from …
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Lung cancer rehab study aims to pinpoint what really matters for patients
Knowledge-focused Not yet recruitingThis study will enroll 63 people with advanced non-small cell lung cancer whose disease has been stable for at least 6 months. Participants will take part in a 3-month rehabilitation program that includes physical activity. Researchers will measure quality of life, hand grip stre…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Emergency intubation linked to higher pneumonia risk, new study to confirm
Knowledge-focused Not yet recruitingThis study looks at whether patients who get a breathing tube in an emergency are more likely to develop pneumonia than those who get one in a planned setting. Researchers will review medical records of 600 adults intubated in 2024. The goal is to understand the risk and improve …
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
New study aims to predict which cancer patients struggle most with eating
Knowledge-focused Not yet recruitingThis study looks at how cancer and its treatments change the way people experience food, including taste, mouth health, and overall eating pleasure. Researchers will ask 180 adults with different cancers to fill out a detailed questionnaire about their eating habits and feelings.…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Could a simple patch replace daily spirometry for COPD patients?
Knowledge-focused Not yet recruitingThis study tests a wearable patch called WearME-Pro that tracks lung function in people with COPD during daily life. Over 10 months, 82 adults will use the patch at home and compare its readings to a standard handheld spirometer. The goal is to see if the patch is accurate, easy …
Sponsor: LASARRUS Clinic and Research Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Tiny study aims to Fine-Tune ventilator settings for ARDS
Knowledge-focused Not yet recruitingThis study looks at how different levels of ventilator pressure affect the heart and lungs in 20 patients with moderate-to-severe ARDS. Researchers will test three pressure settings to see which one best balances lung collapse and overstretching while keeping the heart pumping we…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New strategy aims to prevent breathing trouble after hernia repair
Knowledge-focused Not yet recruitingThis study looks at a new way to close the belly wall during large hernia surgery to prevent breathing problems right after the operation. Doctors will use standard breathing measurements during surgery to decide the best closure method. The study will include 50 adults who are a…
Sponsor: Swissmed Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Gut bacteria may predict severe RSV in kids
Knowledge-focused Not yet recruitingThis study looks at whether the types of bacteria in a child's gut can influence how sick they get from RSV, a common virus that can cause severe breathing problems in infants. Researchers in Vietnam will compare the gut bacteria and immune responses of 250 children with mild ver…
Sponsor: Phuc Huu Phan • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Can a smart imaging vest help kids breathe easier on a ventilator?
Knowledge-focused Not yet recruitingThis study looks at whether using a special imaging technique called Electrical Impedance Tomography (EIT) can help doctors perform safer lung recruitment maneuvers in children with acute respiratory distress syndrome (ARDS). The researchers will enroll 8 children on ventilators …
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
AI model aims to predict lung disease progression
Knowledge-focused Not yet recruitingThis observational study will collect data from 1000 people with idiopathic pulmonary fibrosis (IPF) across multiple Italian centers. Researchers will use machine learning to build a model that predicts disease progression, acute flare-ups, and response to treatment. The goal is …
Sponsor: University of Modena and Reggio Emilia • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Tiny noses, big clues: study hopes nose bugs predict preterm lung disease
Knowledge-focused Not yet recruitingThis study follows 270 preterm babies (born before 32 weeks) from birth to age 3. Researchers will regularly swab their noses to analyze the bacteria and other microbes living there. The goal is to see if the nose microbiome can predict which babies will develop bronchopulmonary …
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
New digital health tool aims to simplify care for patients with multiple chronic illnesses
Knowledge-focused Not yet recruitingThis study tests a new digital health tool designed to help adults aged 40 and older who have two or more long-term health conditions, like high blood pressure, diabetes, or depression. The tool includes an electronic system to guide doctors, telemedicine for specialist visits, a…
Sponsor: Centre for Chronic Disease Control, India • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Lung cancer drug anlotinib tested in Real-World review after treatment failure
Knowledge-focused Not yet recruitingThis study looks back at medical records of 350 people with advanced non-small cell or small cell lung cancer who took anlotinib after their previous treatment stopped working. The goal is to see how well anlotinib works and how safe it is when used in later lines of therapy. The…
Sponsor: Henan Cancer Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Simple blood test may predict lung damage in autoimmune diseases
Knowledge-focused Not yet recruitingThis study looks at a blood protein called FAP, which is linked to tissue scarring and inflammation. Researchers will measure FAP levels in people with rheumatoid arthritis and systemic sclerosis, as well as healthy volunteers, and compare them with standard tests and lung functi…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Could a simple chest strap replace invasive heart monitoring in the ICU?
Knowledge-focused Not yet recruitingThis study will test a new, non-invasive method called EIT Pulse Wave to measure blood flow to the lungs and predict heart stroke volume in critically ill patients. Researchers will compare it to the standard Swan-Ganz catheter, which is invasive. The study involves 19 adults in …
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Blood test could unlock secrets of lung disease immunity
Knowledge-focused Not yet recruitingThis study looks at how the immune system works in people with lung diseases like asthma, COPD, pneumonia, and tuberculosis. Researchers will take a single blood sample from 100 adults to study immune cell changes during inflammation and infection. Participants won't receive dire…
Sponsor: Research Center Borstel • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Hidden problem: many women with COPD may suffer from leakage during rehab
Knowledge-focused Not yet recruitingThis study will check how common urinary incontinence is in women with COPD who are doing pulmonary rehabilitation. Researchers will measure leakage with a pad test and ask about quality of life. The goal is to understand the problem better so future treatments can be developed.
Sponsor: Fondation Hôpital Saint-Joseph • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Scientists investigate mysterious lung infection in south china
Knowledge-focused Not yet recruitingThis study looks at a lung infection called NTM lung disease in South China. Researchers will review medical records of about 1,500 patients and collect samples from around 100 current patients to learn how the immune system reacts. The goal is to help doctors diagnose and manage…
Sponsor: Eighth Affiliated Hospital, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Painless ultrasound could replace invasive breathing tests
Knowledge-focused Not yet recruitingThis study tests whether a special ultrasound technique called shear wave elastography can measure how hard someone is working to breathe. Currently, doctors must insert a balloon-tube into the esophagus to measure breathing effort, which is uncomfortable. Researchers will compar…
Sponsor: Groupe Hospitalier du Havre • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Blood test may predict immunotherapy success in cancer patients
Knowledge-focused Not yet recruitingThis study looks at whether tiny particles in the blood, called extracellular vesicles, can help doctors predict if immunotherapy will work for people with advanced lung cancer or melanoma. Researchers will collect blood samples from 378 patients before and during standard treatm…
Sponsor: Centre Georges Francois Leclerc • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Simple ultrasound may predict ventilator weaning failure in ICU patients
Knowledge-focused Not yet recruitingThis study tests whether a special ultrasound technique, called VExUS, can predict which ICU patients will have trouble breathing on their own after being on a ventilator. Researchers will scan the veins of 350 patients just before a breathing trial. The goal is to see if signs o…
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Can 'Teach-Back' training help patients breathe better after surgery?
Knowledge-focused Not yet recruitingThis study tests whether a special teaching method called '5T Teach-Back' helps patients learn breathing exercises and use a spirometer (a device that measures how well you breathe) before abdominal surgery. The goal is to see if this method improves patients' knowledge, skills, …
Sponsor: Suleyman Demirel University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New study to track RSV impact on turkish toddlers in ERs
Knowledge-focused Not yet recruitingThis study will observe up to 4,000 children under 5 years old who test positive for RSV and visit emergency departments in Turkey. Researchers will track how many children need to be admitted to the hospital or intensive care, and what treatments they receive. The goal is to bet…
Sponsor: Eskisehir Osmangazi University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC